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Investigation of Buildup Dose for Therapeutic Intensity Modulated  
Photon Beams in Radiation Therapy  
 
Khosrow Javedan 
 
ABSTRACT 
 
Buildup dose of Mega Voltage (MV) photon beams can be a limiting factor in intensity- 
modulated radiation therapy (IMRT) treatments. Excessive doses can cause patient 
discomfort and treatment interruptions, while underdosing may lead to local failure. 
 
Many factors which contribute to buildup dose, including the photon beam energy 
spectrum, scattered or contaminant radiation and their angular distribution, are not 
modeled well in commercial treatment planning systems. The accurate Monte Carlo 
method was employed in the studies to estimate the doses. 
 
Buildup dose of 6MV photon beams was investigated for three fundamentally different 
IMRT modalities: between Helical TomoTherapy and traditional opposed tangential 
beams, solid IMRT and multileaf collimator (MLC)-based IMRT techniques. Solid 
IMRT, as an alternative to MLC, achieves prescription dose distribution objectives, 
according to our study. 
ix 
 
Measurements and Monte Carlo calculations of buildup dose in chest wall treatment were 
compared between TomoTherapy IMRT and traditional tangential-beam technique. The 
effect of bolus in helical delivery was also investigated in this study. 
 
In addition, measurements and Monte Carlo calculations of buildup dose in solid IMRT 
and MLC based IMRT treatment modalities were compared. A brass step compensator 
was designed and built for the solid IMRT. Matching MLC step sequences were used for 
the MLC IMRT.  
 
This dissertation also presents the commissioning of a Monte Carlo code system, 
BEAMnrc, for a Varian Trilogy linear accelerator (LINAC) and the application in 
buildup dose calculation. Scattered dose components, MLC component dose and mean 
spectral energy for the IMRT treatment techniques were analyzed. 
 
The agreement between measured 6MV and calculated depth dose and beam profiles was 
(± 1% or ±1 mm) for 10x10 and 40x40 cm2 fields. The optimum electron beam energy 
and its radial distribution incident on tungsten target were found to be 6 MeV and 1 mm 
respectively. 
 
The helical delivery study concluded that buildup dose is higher with TomoTherapy 
compared to the opposed tangential technique in chest wall treatment. The solid and 
MLC IMRT comparison concluded that buildup dose was up to 7% lower for solid IMRT 
compared to MLC IMRT due to beam hardening of brass. 
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CHAPTER 1  INTRODUCTION 
 
1.1  Synopsis 
 
Determination of buildup dose of therapeutic megavoltage photon beams has been an 
active area of research in radiation therapy since before the introduction of 3D conformal 
radiation therapy(1), a precursor to IMRT(2). Accurate knowledge of buildup dose of 
IMRT is necessary, especially for IMRT cases treated with concurrent radiosentisising 
chemotherapy where excessive dose in the buildup region can cause skin infection and 
treatment interruption, and underdosing may lead to local failure. Dose in this region 
must accurately be known so that the calculated dose by the treatment planning system 
(TPS) is properly interpreted. A radiation oncologist may have to compromise a known 
therapeutic dose in order to limit the skin dose calculated by the treatment planning 
system (TPS). Historically, superficial dose is not well predicted by commercial TPS. 
Literature shows TPS overestimate dose in the buildup region by up to 19%. Literature 
also shows the expected calculation accuracy for pass fail criteria in the buildup region 
when commissioning the TPS is 20% of the normalization dose for open fields(3). It is up 
to the individual physicist to accurately assess the shallow dose and incorporate that into 
evaluating the TPS dose in the buildup region. 
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Many factors contribute to buildup dose, including the photon beam energy spectrum, 
contaminant electrons and scattered particle angular distribution, and effect of 
immobilization devices which are not properly modeled in commercial treatment 
planning systems. The dosimetrical differences in buildup regions between different 
treatment modalities, such as helical IMRT delivery with TomoTherapy versus traditional 
wedge pair technique, and MLC-based versus compensator-based IMRT, cannot be 
accurately obtained by comparing treatment plans alone. 
 
This dissertation work investigates the dosimetrical differences in buildup region between 
TomoTherapy versus conventional wedge pair technique with and without bolus, and 
IMRT with MLC versus solid brass compensator with measurement and Monte Carlo 
method. Significant work was carried out in establishing and running the Monte Carlo 
Code system on the Moffitt Computer Cluster and in commissioning the BEAM to 
perform radiation transport calculations with the same beam characteristics as the 6MV 
Varian Clinac 2100 beam. Use of this code was an essential part of this dissertation. 
 
1.2  Objective of the Study 
 
The objective of the study was to investigate the dosimetrical differences including the 
dose and dose gradient in the buildup region of therapeutic photon beams from 3 different 
IMRT modalities: TomoTherapy, compensator-based IMRT and MLC-based IMRT. The 
dose and relative dose distributions were measured with film, ion chamber and MOSFET 
detectors and calculated with Monte Carlo to verify the doses. The results of the study 
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were used to answer important clinical concerns related to the IMRT technique used. For 
example, whether chest wall treatment with TomoTherapy requires the use of bolus 
material, whether solid IMRT can achieve the prescription dose distribution objectives as 
an alternative to MLC-based IMRT, and whether buildup dose of IMRT delivery with 
compensator on the Varian Clinac 2100 LINAC is a concern. 
 
The secondary objective and essential part of this dissertation was to install the EGSnrc, 
BEAMnrc Monte Carlo code system on the institution’s computer cluster and test to 
ensure proper functionality of the installed code and related programs, such as 
DOSXYZnrc, statdose, BEAM_DP and ctcreate. The Monte Carlo BEAM was 
commissioned to perform radiation transport calculations with the same beam 
characteristics as the 6MV beam of the LINAC used.  
 
1.3  Dissertation Outline 
 
The European format of using peer-reviewed journal articles in compiling the bulk of this 
manuscript has been adopted for this dissertation. Therefore, there may be overlapping 
text in various chapters of this work. This was ascertained to be the most efficient 
arrangement in order to preserve the overall quality of this work. 
 
Chapter 2 describes the commissioning of the Monte Carlo simulation code BEAMnrc 
and DOSXYZnrc for the application in the dissertation studies.  
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Chapter 3 discusses the skin dose differences between TomoTherapy chest wall 
irradiation and traditional linear-accelerator-based tangential-beam technique. Adequate 
treatment of the chest wall using the tangential-beam technique is reviewed. Chest wall 
plans that were generated using two commercial treatment planning systems which 
produce plans for fundamentally different dose delivery methods, along with Monte 
Carlo dose calculations were evaluated to determine if bolus was required for adequate 
skin dose from the two treatment techniques.  
 
Chapter 4 investigates the use of solid brass modulators for intensity-modulated radiation 
therapy (IMRT) delivery of large targets as an alternative to step and shoot delivery with 
multileaf collimator (MLC)(15). This study was conducted during the initial use of solid 
modulators in the department to investigate the device’s ability to reproduce the planned 
isodose distribution for a large target which overlapped normal critical structures. An 
ideal modulator is one which faithfully reproduces the field’s ideal intensity map as 
planned, both dosimetrically and spatially. The dose volume histogram (DVH) of IMRT 
plans with solid modulator and MLC was compared. The absolute point doses were 
measured with a calibrated ionization chamber. The relative dose distribution was 
measured with EDR2 film and a commercial diode array device to ensure the planned 
isodoses matched the delivered isodose distributions. 
 
Chapter 5 investigates the dosimetrical differences in buildup region of a 6MV beam 
between MLC- and compensator-based IMRT with measurement and Monte Carlo 
method. Photon beam energy spectrum, contaminant electrons and scattered particle 
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angular distribution affect the buildup dose and are not properly modeled in commercial 
treatment planning systems. Literature suggests such systems overestimate the dose in 
this region. Since buildup dose near skin is not accurately predicted by commercial 
treatment planning systems, accurate Monte Carlo was used to calculate the near skin 
buildup dose at depth of 1.0-5.0 mm. Skin dose variation with SSD, field size and beam 
incidence angle was investigated. Component doses of contaminant photons, contaminant 
electrons and MLC component dose was calculated for the two IMRT delivery systems. 
Mean spectral energy as a function of brass modulation was calculated to show beam 
hardening effect responsible for enhanced skin sparing of the solid modulator. 
 
1.4  Limitation of this Work 
 
The Monte Carlo simulation package BEAMnrc was commissioned for the 6MV photon 
beam from Varian Trilogy LINAC equipped with MLC.  However, Varian Trilogy 
machine also produces 15MV photon beams and 6 electron beams of 6 MeV to 22 MeV 
(commissioning these energies is left for future work). Due to simplified design of the 
brass step jig, we could accurately model the steps of solid modulator and dose 
equivalent MLC sequences to perform simulation and dose and component dose 
calculation in the buildup region. Clinical IMRT beams may require highly complex dose 
distribution in X, Y and Z direction, modulated with solid brass or MLC. The modeling 
of such a complex device with BEAMnrc was out of scope of this research. 
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CHAPTER 2  MONTE CARLO SIMULATION 
 
2.1 Synopsis 
Monte Carlo simulation is a numerical solution to a problem that is not easily solved by 
analytical methods. The problem models objects (i.e, high energy electron and photon 
radiation) that interact with other objects (i.e, matter) in a well defined environment. A 
solution (result of interaction based on actual radiation transport physics) is determined 
by repeated random sampling using computational algorithms to calculate the result. 
 
Monte Carlo simulations are employed in many fields such as radiation physics, 
chemistry, space, finance, mathematics, and other disciplines that may require a 
quantitative solution to a problem which can be approximated by statistical sampling.  
Monte Carlo techniques for simulating radiation transport of electrons and photons are 
used extensively in the field of medical physics and radiation dosimetry(4).  Monte Carlo 
simulation has been found to be the most accurate technique to estimate the dose 
deposited in tissue based on the actual radiation transport physics(5, 6). 
 
2.2  Monte Carlo Simulation of  Megavoltage Photon Beam 
 
Monte Carlo simulation starts as the monoenergetic electron beam with initial kinetic 
energy Eki interacts with the nuclei of the high Z tungsten target atom mostly by the way 
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of Coulomb interaction. The incident electrons also scatter and lose energy through 
production of x-ray bremsstrahlung photons. Bremsstrahlung photons are produced at a 
rate expressed by the mass radiative stopping power (dT/ρdx)r , in units of MeV cm2/g as 
in equation 1, 
 
 ( )22
2 1
cmA
Z
dx
dT
or
∝⎟⎟⎠
⎞
⎜⎜⎝
⎛
ρ
  (1) 
 
Z2/A refers to the atomic number and mass number of the medium and (moc2) is the rest 
energy of the charged particle. Bremsstrahlung is produced at higher rate for the high Z 
target compared to low Z target due to the Z2 dependence. 
 
Each particle is transported and tracked as it passes through and interacts with various 
components in the accelerator head in its path. Such components are the primary 
collimator (defines radiation port), thin vaccum window (target assembly kept in 
vacuum), flattening filter (has cone shaped geometry, made of low-medium Z material, 
reduces the forward peaked photon fluence more in the center than periphery to produce 
flat beam), transmission chamber (monitors dose, beam flatness and symmetry), mirror 
(locked in place in x-ray mode to project field light on surface), secondary jaws (high Z 
material defines field size), MLC (high Z material shapes fields with motorized leaves) 
and the intervening air until it reaches the end of its history. It then either escapes the 
defined geometry or deposits its energy at the end of its track.  
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The end of each particle’s track is determined by its cut off energy. Once particle energy 
falls below its cut off energy, the particle is no longer tracked and all of its energy is 
deposited at the site, notwithstanding that Compton scattering is the predominant mode of 
interaction for the 6MV photon beam, interacting with low Z absorbers such as the 
flattening filter material, muscle and water. 
 
2.3  Materials and Methods 
 
2.3.1  Monte Carlo Simulation of the Varian Clinac 6MV Beam 
 
An EGSnrc(7, 8)-based Monte Carlo simulation package for clinical radiation treatment 
units, BEAMnrc (9), was used to precisely characterize a Varian Clinac 2100 LINAC 
(Varian Medical Systems, Palo Alto, CA) equipped with MLC. 
 
The detailed drawing including the material and geometry for the accelerator head 
components and the distance of each component from the target was acquired from the 
manufacturer. The component modules (CMs) of BEAMnrc were used to precisely model 
the accelerator head components in the accelerator input file. 
 
2.3.2  Component Modules of BEAMnrc 
 
Component modules are blocks with front surface and back surface. All blocks are 
completely independent. Various CMs are used to model exact geometry and material of 
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different components in the LINAC head. Each component assumes a horizontal slab 
portion of the accelerator with respect to beam axis. Each specialized CM can be used 
more than once to model different parts of the accelerator, therefore a unique name was 
given to each component’s CM for the simulation. 
 
2.3.3  CMs for Varian Clinac 2100 Model 
 
The CMs that were used to model the Varian Clinac 2100 were SLABS for target, 
CONS3R for primary collimator, SLABS for vacuum window, FLATFIL for flattening 
filter, CHAMBER for transmission monitor chamber, MIRROR for mirror, JAWS for 
secondary collimator jaws, SLABS for air gap, and CHAMBER as phantom for phantom 
defined at 100 cm SSD (source to surface distance). Phantom in BEAMnrc input file was 
used to simulate depth dose in water along the central-axis. 
 
The MLC was modeled using VARMLC CM in BEAMnrc. This module models the 
leaves, the air gap between leaves, the leaf tongue-in-groove and the driving screws at the 
top and bottom of each leaf.  
 
The accelerator model that was used to perform MC simulations is shown in Figure 1. 
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Figure 1.  The accelerator model for the 6MV Varian 2100 and its component modules in 
(a) XZ view, and (b) YZ view.  The accelerator components are the target (1), the 
primary collimator (2), the vacuum window (3), the flattening filter (4), the transmission 
chamber (5), the secondary jaws (6) and the MLC (7), as shown in the figure. 
 
2.3.4  DOSXYZnrc 
 
DOSXYZnrc(13) is another Monte Carlo simulation program which is used to calculate 
dose distribution in a simple rectilinear phantom geometry. The phantom is defined 
within the program by the user. For example a 40x40x40 cm3 water phantom was 
defined. Also the voxel size in X, Y, and Z dimension was input and dose distribution 
calculation planes either parallel or normal to the beam axis were defined. Percent depth 
dose and beam profiles were calculated using this program.  
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2.3.5  Measured Beam Data 
 
Beam data including the percent depth dose and beam profiles were acquired during the 
commissioning of the LINAC. Scanned beam data were measured with ion chamber and 
diode using a commercial water scanning system (Scanditronix-Welhoffer RFA 300). 
 
2.3.6  Accelerator Simulation Parameters 
 
Three electron beam incident energies of 5.7, 6.0 and 6.3 MeV were investigated. The 
calculated percentage depth dose and beam profiles were compared with the 6MV 
scanned beam data to determine the optimum value for the electron beam energy incident 
on the target. 
 
The incident electron beam source was chosen as parallel circular beam with a uniform 
distribution (ISOURCC=1), as shown in Figure 2. In the accelerator input file, this source 
model takes four input parameters, the beam radius and the (x, y, z)-direction cosines. 
The x- and y-axis direction cosine was set to zero and the z-axis direction cosine was set 
to 1 to define the incident beam orientation parallel to the z-axis and pointing down the 
accelerator. 
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Figure 2.  Source model as parallel circular beam with a uniform distribution.  
(ISOURC=1)(9) is shown. The beam radius and the x,y,z -direction cosines are the 4 
parameters used to define the source. The parallel circular beam is always assumed to be 
incident on the center of front of the first component module (i.e. at Z_min_CM(1)). 
 
Based on the information in the literature (10-12), the parameters of the primary electron 
beam incident on the high Z target, including its energy and beam radius, were chosen to 
closely match the simulated beam profiles and percentage depth dose curves with the 
measured beam data.  
 
Simulation parameters used for BEAMnrc and DOSXYZnrc were the Global cut off 
energy: for electrons ECUT= 0.70 MeV and for photons PCUT = 0.01 MeV. Electron 
range rejection and photon forcing was turned off for all simulations. Electron range 
rejection is used to save computing time during simulations where the range of charged 
particle is calculated and its history is terminated if it cannot leave the region it is in. 
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Photon forcing, where users force the photon to interact in a specific CM, improves 
statistics.  
 
The cross section data for all material densities in the accelerator for particles with kinetic 
energy down to 10 KeV were from PEGS4 data file 700icru.pegs4dat. 
 
Selective bremsstrahlung splitting was turned on to save simulation time. The minimum 
and maximum number of bremsstrahlung photons produced by each bremsstrahlung 
event was set to 20 and 200 brems photons. The effective field size in which selective 
bremsstrahlung splitting probabilities are calculated was set to 30 for the 10x10 cm2 field 
and 50 for the 40x40 cm2 field respectively. This technique improved the simulation time 
by a factor of 6 compared to no variance reduction. 
 
Typically between 108-109 histories are needed depending on the pixel size in the X, Y 
and Z dimension in order to yield a statistically acceptable solution, as fewer numbers of 
particles interact in smaller volume.  
 
2.3.7  Phase Space File 
 
Phase space file is one of the most important outputs of BEAMnrc. Phase space file is a 
binary file and is usually tens of gigabytes of RAM in size. Information about each 
particle history including its charge, energy, position, direction of incidence and latch is 
stored in the phase space file. BEAMnrc outputs phase space file for planes that were 
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scored at the end of each component module, CM. The user specifies the desired plane 
for phase space file to be scored by making the selection in the BEAMnrc input file.  
 
The phase space file can be used as a radiation source for further simulations in order to 
save time and hard disk space. For example, particles can be collected in the phase space 
file at the end of secondary jaws. The phase space file is then used as radiation source to 
simulate varying field sizes defined by MLC which is below the jaws (which is now the 
first CM as opposed to the target) or even downstream further away from the jaws where 
varying thickness compensators are simulated without having to resimulate the entire 
accelerator for each field size or compensator thickness, thus significantly speeding up 
the simulation. 
 
The BEAM data processor BEAM-dp (14) was used to analyze the phase space files. The 
program was accessed using graphical user interface gui, beamdp_gui command in the 
accelerator directory. The program outputs the requested information such as fluence 
versus position, energy fluence versus position, energy fluence distribution, mean energy 
distribution, and angular distribution of the simulated electrons and photons in the phase 
space file which can be plotted for visual analysis. 
 
The 6MV photon spectrum, the energy fluence distribution, mean energy distribution 
versus off axis distance for 10x10 and 40x40 cm2 fields, fluence and energy fluence 
across the 10x10 cm2 and 40x40 cm2 fields, and the photon spectra were calculated. 
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2.3.8  Computer Cluster for MC Simulation 
 
A Rocks 5.2 cluster of 22 computers has been used to accept independent batch jobs 
submitted by the MC code to the Q and distributed to local nodes by the master. The 
cluster runs Cent OS 5.3 distribution and is configured with 22 local nodes. One master 
server distributes the jobs to local nodes. Each compute node has two Xeon X5460 (3.2 
GHz) Quad core processor with 32 GB memory. Compute nodes are interconnected by a 
private switch at 1 Gbps. Each compute node can handle simulation calculations 
independently of other nodes, therefore as many as 176 independent simulation jobs can 
be run simultaneously. 
 
2.4  Results 
 
2.4.1  Comparison Between Measured and Calculated Percent-Depth-Dose (PDD) Curves 
 
Good agreement (± 1% or ±1 mm) is seen between calculated PDD curves (circle) for all 
beam energies (5.7, 6, 6.3MeV) and measured 6MV PDD curves (solid line) for (a) 
10x10 cm2 and (b) 40x40 cm2 fields in the buildup to 5 cm depth range as in Figures 3 
(a,b), 4 (a,b) and 5(a,b). The calculated PDD curves for 5.7 MeV beam were 1-2% lower 
than measured 6MV PDD curve beyond 5 cm depth for 10x10 and 40x40 cm2 fields as in 
Figure 3 (a,b). 
16 
 
 
 
(a) 
 
(b) 
 
Figure 3.  Overlay of measured 6MV photon depth dose curves (solid line) and Monte 
Carlo (circle) for 100 cm SSD and field size (a) 10x10 cm2, and (b) 40x40 cm2 calculated 
with 5.70 MeV electron beam incident on the target. 
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(a) 
 
 
(b) 
 
Figure 4.  Overlay of measured 6MV photon depth dose curves (solid line) and Monte 
Carlo (circle) for 100 cm SSD and field size (a) 10x10 cm2, and (b) 40x40 cm2 calculated 
with 6.0 MeV electron beam incident on the target. 
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(a) 
 
 
(b) 
 
Figure 5.  Overlay of measured 6MV photon depth dose curves (solid line) and Monte 
Carlo (circle) for 100 cm SSD and field size (a) 10x10 cm2, and (b) 40x40 cm2 calculated 
with 6.30 MeV electron beam incident on the target. 
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2.4.2  Comparison Between Measured and Calculated Beam Profiles 
 
2.4.2.1  10x10 cm2 Beam Profile  
 
For 10x10 cm2 fields, good agreement is seen between the measured 6MV beam profiles 
(solid line) and calculated (circle) beam profiles of the same fields at dmax, 5 cm and 10 
cm depth for beam energies of 5.7 MeV as in Figure 6 (a-f), 6.0 MeV in Figure 7 (a-f), 
and 6.3 MeV in Figure 8 (a-f) respectively. 
 
The agreement between measured and calculated beam profiles for 10x10 cm2 beam at 
dmax, 5 and 10 cm depth was (± 1% or ±1 mm) as in Figures 6 (a,c), 7 (a,c,e) and 8 (a,c, 
e).for all beam energies and depths except 5.7 MeV beam profile at 10 cm depth was 1-
2% lower than that measured as in Figure 6(e). There was also a small increase in the size 
of the horn at dmax for the 5.7 MeV beam, as in Figure 6(a). 
 
2.4.2.2  40x40 cm2 Beam Profile  
 
For the 40x40 cm2 fields, there was good agreement (± 1% or ±1 mm) between measured 
6MV beam profiles and calculated beam profiles of 6.0 MeV and 6.3MeV beams for 
most depths, as in Figures 7 (b,d,f) and 8 (d,f), except 6.3 MeV beam profile at dmax was 
1-2% lower than measured as in Figure 8 (b). The calculated 5.7 MeV beam profile, 
however, exhibited +6% increase in the size of the horn at all depths compared with the 
6MV measured beam profile for 40x40 cm2 field, as in Figure 6 (b,d,f). 
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(a) 
 
 
(b) 
Figure 6.  Overlay of measured 6MV photon beam profile (solid line) and Monte Carlo 
(circle) for 10x10 and 40x40 cm2 fields at 100 cm SSD and at depths dmax (a, b), 5 cm 
(c, d) and 10 cm (e, f) in water, with simulated electron beam energy incident on the 
target was 5.70 MeV. 
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(c) 
 
 
(d) 
Figure 6.  (Continued) 
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(e) 
 
 
(f) 
 
Figure 6.  (Continued) 
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(a) 
 
 
(b) 
Figure 7.  Overlay of measured 6MV photon beam profile (solid line) and Monte Carlo 
(circle) for 10x10 and 40x40 cm2 fields at 100 cm SSD and at depths dmax (a, b), 5 cm 
(c, d) and 10 cm (e, f) in water, with simulated electron beam energy incident on the 
target was 6.0 MeV. 
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(c) 
 
 
(d) 
Figure 7.  (Continued) 
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(e) 
 
 
(f) 
Figure 7.  (Continued) 
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(a) 
 
 
(b) 
Figure 8.  Overlay of measured 6MV photon beam profile (solid line) and Monte Carlo 
(circle) for 10x10 and 40x40 cm2 fields at 100 cm SSD and at depths dmax (a, b), 5 cm 
(c, d) and 10 cm (e, f) in water, with simulated electron beam energy incident on the 
target was 6.30 MeV. 
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(c) 
 
 
(d) 
Figure 8.  (Continued) 
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(e) 
 
 
(f) 
Figure 8.  (Continued) 
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2.4.3 6MV Spectrum and Fluence 
 
The photon spectrum calculated here for the region 0 ≤ r ≤ 3 cm inside a 10x10 cm2 field 
at 100 cm SSD is shown in Figure 9.   
 
Figure 10 shows the energy fluence distribution for the 5.7, 6.0 and 6.3 MeV beam 
calculated at the surface of the phantom at 100 cm SSD, 10x10 cm2 field of mixed 
photons and charged particles.  The 5.7 MeV, 6.0 MeV and 6.3 MeV electron beam 
striking the bremsstrahlung target resulted in mean energy of 1.45 MeV, 1.55 MeV and 
1.58 MeV beam at the phantom surface respectively. 
 
Figure 11 (a) shows that the mean energy distribution at the phantom surface for 10x10 
cm2 field is relatively flat compared to that for 40x40 cm2 field.  Figure 11 (b) shows the 
mean energy distribution across 40x40 cm2 field decreased with off axis distance toward 
the field edge. The mean energy at the field edge was 0.25 MeV lower compared to that 
at central axis for all beams. There is more low energy scatter dose contribution near the 
field edge compared to central axis for large fields.  
 
Figure 12 (b) shows the fluence increased with 20 cm off axis distance reaching 135 % of 
central axis, near the field edge. These are mostly lower energy particles that were 
attenuated by thinner part of the flattening filter toward the field edge resulting in 
relatively flat energy fluence profile across the 40x40 cm2 field, as in Figure 13. 
 
30 
 
Figure 13 shows the size of the horn of energy fluence profile across 40x40 cm2 field 
decreased with increasing energy of primary electron beam incident on the target. This is 
because the relative intensity of photons increases with energy. Fluence of forward 
directed photons down the axis at small angles increases with energy more than it does at 
larger angles and away from central axis toward the field edge. Therefore the size of the 
horn decreases with increasing energy, as seen in Figure 13. 
 
 
 
Figure 9.  Calculated photon spectrum in the form of planar fluence histogram for the 
region 0 ≤ r ≤ 3 cm inside a 10x10 cm2 field at 100 cm SSD. 
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Figure 10.  Calculated energy fluence distribution for 10x10 cm2 field.  The simulated 
electron beam energy incident on the target was 6.30 MeV top curve, 6.0 MeV middle 
curve and 5.7 MeV the bottom curve. 
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(a) 
 
(b) 
Figure 11.  Calculated mean energy distribution across (a) 10x10 cm2 field and (b) 40x40 
cm2 field.  The simulated electron beam energy incident on the target was 6.30 MeV top 
curve, 6.0 MeV middle curve and 5.7 MeV the bottom curve. 
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(a) 
 
 
(b) 
 
Figure 12.  Calculated fluence versus position for (a) 10x10 cm2 and (b) 40x40 cm2 field.  
The simulated electron beam energy incident on the target was 5.7 MeV top curve, 6.0 
MeV middle curve and 6.3 MeV the bottom curve. 
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Figure 13.  Calculated energy fluence versus position for 40x40 cm2 field.  The simulated 
electron beam energy incident on the target was 5.7 MeV top curve, 6.0 MeV middle 
curve and 6.3 MeV the bottom curve. 
 
2.5  Conclusions  
 
Since the calculated percentage depth dose and 10x10 cm2 beam profiles were not as 
sensitive to changes in primary electron beam energy as were the large beam profiles, the 
match between measured and calculated 40x40 cm2 beam profiles were used to find the 
optimum electron beam parameters in commissioning of the BEAM. 
 
The optimum electron beam incident on the target had a radius of 1 mm with energy of 
6.0 MeV respectively. 
 
35 
 
 
 
CHAPTER 3  PAPER I: SKIN DOSE STUDY OF CHEST WALL TREATMENT 
WITH TOMOTHERAPY 
 
This study compares the dosimetric differences between TomoTherapy chest wall 
irradiation and traditional linear-accelerator-based tangential-beam technique. 
TomoTherapy treatment plans with and without bolus were compared with tangential-
beam plans. Plans were also generated for phantom studies and point doses were 
measured using MOSFET dosimetry to verify the adequate skin dose. Monte Carlo 
simulations of static beams of both techniques were performed and dosimetry was 
compared. 
(Jpn J Radiol. 2009; 27:355-362) 
 
3.1  Synopsis 
 
The tangential-beam technique frequently presents challenges in radiation dose 
homogeneity to the target. To ensure adequate dose to the skin, bolus is often used.  
TomoTherapy has already been shown to improve target conformity and homogeneity in 
other disease sites(16, 17). Because of the tangential delivery technique and lack of 
flattening filter in TomoTherapy accelerators, we hypothesize that during chest wall 
irradiation using TomoTherapy, the skin dose will be adequate without bolus. Monte 
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Carlo simulations and measurements confirmed that beams from TomoTherapy deliver 
higher skin dose than a standard linear accelerator. Skin dose also increases with the 
incident angle of the beams. Due to the characteristics of the TomoTherapy beam and 
delivery technique, chest wall treatment plans from TomoTherapy showed adequate skin 
dose (over 75% of prescribed PTV dose) even without bolus. 
 
3.2  Introduction 
 
Many treatment modalities and techniques are available for the post-mastectomy 
radiotherapy to treat the chest wall(18-20). The most commonly used technique is opposed 
tangential external beams to cover all the potential tumor-bearing chest wall tissues(21). A 
supraclavicular field may be needed to adequately cover the regional nodes, if they are at 
risk(22). Adequate treatment of the chest wall using the tangential-beam technique 
requires: 
1. Homogeneous dose distribution over the chest wall; 
2. Minimal dose to lungs, the opposite breast, and the heart; 
3. Precise matching between the inferior border of the supraclavicular field and 
the superior border of the tangential fields; 
4. Adequate dose to skin and the mastectomy scar (about 75%~90% of the 
prescribed dose); 
5. Adequate dose to the axillary and internal mammary nodes (45~50Gy), when 
they are at risk(21, 23).. 
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These requirements often present challenges for the treatment planning. For example, 
although photon beams of 6MV and lower provide adequate skin dose without using 
bolus every day, there can be poor dose homogeneity, especially if the chest wall 
separation is large(21). Higher energy photon beams improve dose homogeneity for large 
patients, but then bolus must be added to raise the skin dose. Use of bolus has also been 
associated with increased acute skin toxicity(24). Common practice for chest wall 
treatments is to use bolus every other day, even with 6MV photon beams. It is important 
to note that if the bolus and non-bolus plans are rotated, then the goal is not to have 100% 
prescribed dose at the surface, but something closer to 80% of the prescribed dose. 
Superficial dose ranged from 74% to 93% by phantom measurement when incident beam 
angle varied from 0 to 90 degrees with bolus on/off alternatively(25). 
 
Previous investigators have shown that TomoTherapy Hi-Art (TomoTherapy Inc., 
Madison, WI) provides an advantage in a higher skin dose by using skin flash beams. 
Other clinical researchers have demonstrated that TomoTherapy planning usually 
overestimates superficial dose by up to 10% for shallow planning target volumes 
(PTV)(26, 27) which needs to be accounted for while evaluating the skin dose in 
TomoTherapy plans. However, good agreement (<2.5%) between calculated and 
measured skin dose has also been reported(28).  
 
The area at risk represents some combination of the basal layer of the skin and the dermal 
layer which contain the dermal lymphatics(29), and potential cancer cells within the 
lymphatics. Thus, the area at risk which is targeted is not on the surface, but 1 to 5 mm 
38 
 
below the surface. Besides the superficial dose as studied by other groups(30), the focus of 
this study extends to dose gradient at shallow depths in the chest wall. 
 
In this study, clinical cases of chest wall treatment plans are compared. Phantom studies 
were also performed to compare the skin dose differences between the treatment 
techniques. Measurements of skin dose were compared with treatment plans. Monte 
Carlo simulations were also used to confirm the skin dose differences. 
 
3.3  Material and Methods 
 
3.3.1  Patient Cases 
 
A total of 5 previously treated chest wall patients were selected for treatment plan 
comparison. Treatment plans were generated for TomoTherapy and conventional 
tangential-beam technique. Besides PTV radiation dose coverage, dose distributions for 
lungs and heart were also evaluated. However, the skin dose is the primary planning 
parameter in this comparison. 
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3.3.2  TomoTherapy Planning 
 
Clinical cases of chest wall treatment plans and phantom plans to simulate chest wall 
treatment were generated and studied. A collapsed cone convolution/superposition 
algorithm(31) was used for all the plans. Heterogeneity corrections were applied. 
 
The pitch value in all the plans was set at 0.287. The modulation factor was 2.7. The plan 
objective was at least 95% of the PTV volume to receive the prescription dose of 50 Gy. 
Heart dose was limited such that less than 5% of heart volume received less than 20 Gy. 
Lung dose constraints were:  less than 25% of the ipsilateral lung volume received 15 Gy 
and less than 15% of the contralateral lung received 2.5 Gy. Directional blocks were used 
in the TomoTherapy plans to reduce the dose to the lungs and heart. TomoTherapy plans 
without directional blocks were also generated for comparison. 
 
Treatment plans for a Rando Man phantom (The Phantom Laboratory, Salem, NY) were 
also generated for skin dose measurements. A Rando phantom is constructed with 
materials equivalent to soft tissues and skeleton. It simulates realistic human anatomical 
structures. Figure 14 shows examples of the plans. 
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Figure 14.  The TomoTherapy chest wall treatment plans on a male Rando phantom. The 
upper row shows the transverse, coronal and sagittal views of the plan without a bolus, 
and the lower row shows the plan with a bolus. These plans were generated for the skin 
dose measurement using MOSFET dosimeters. Air gaps under the bolus are noticeable 
on the images of the plan with a bolus. 
 
3.3.3  Tangential-Beam Planning 
 
Tangential-beam plans of clinical cases were generated using the XiO planning system 
(Version 4.34.02.1, CMS, Inc, St. Louis, MO) for an Oncor linear accelerator (Siemens 
Medical Solutions USA, Inc. Malvern, PA). Two tangential beams were used in the 
plans. Field-in-field technique(32) was used in some of the tangential-beam plans to 
improve PTV dose homogeneity. Electron beam was included in some of the cases to 
treat the internal mammary region. A superposition algorithm(33) was employed in the 
dose calculation. Heterogeneity correction was turned on to account for lung and bone 
densities. The same contour set of target volumes and critical structures used in each 
TomoTherapy plan was used in the corresponding tangential-beam plan. The photon 
beam energy used in the tangential-beam plans was 6MV, and the electron beam energy 
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was 9 or 12 MeV. Chest wall treatment plans were also generated on a Rando phantom 
for skin dose measurement. 
 
 3.3.4  Monte Carlo Simulation 
 
An EGSnrc(7) based Monte Carlo simulation package for clinical radiation treatment 
units, BEAMnrc(34), was used to simulate linear accelerators with and without a photon 
beam flattening filter. The absence of a flattening filter in a TomoTherapy unit is one of 
the major differences compared to conventional linear accelerators. A total of 1×108 
electrons with the incident energy of 6 MeV were simulated in each accelerator head. 
Phase space files, in which physical parameters of all the particles passing through the 
plane of interest is stored, were scored at the end of the secondary jaws. The phase space 
files were then used as radiation sources in phantom dose distribution calculations using 
DOSXYZnrc(13), another Monte Carlo simulation computer program for simple geometry 
media.  
 
Another major difference between a conventional linear accelerator and Tomotherapy is 
that the source to axis distance (SAD), for a conventional linear accelerator is 100 cm 
while it is 85 cm for TomoTherapy. Therefore a difference of source to surface distance 
(SSD) of 15 cm was also compared in Monte Carlo simulations. 
 
Dose in phantom versus radiation beam incident angle was studied to understand the dose 
effect at shallow depth of the helical delivery technique that TomoTherapy uses and 
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angled beams in tangential-beam technique. The beam size used in the simulation was 
5×5 cm2. The resolution of the dose grid along the central axis direction in the water 
phantom was 3×3×0.15 cm3, where 0.15 cm was along the direction perpendicular to the 
phantom surface. The rotation axis of the beams (isocenter) was at the phantom surface. 
 
3.3.5  Dose Measurements 
 
The mobileMOSFET TN-RD-16 wireless dose verification system (Thomson & Nielsen 
Electronics Ltd, now Best Medical Canada, Nepean, Ontario, Canada) was used for the 
dose measurements. According to the specifications, the system has an accuracy of 2% at 
200 cGy dose level at standard bias. 
 
The MOSFET readings were cross checked with ion-chamber measurements using the 
TomoTherapy monthly static output in reference geometry setup. With this setup(35), 
stationary dose delivery was used to deliver about 200 cGy to the depth of maximum 
dose, dmax, of a solid water phantom. Chamber reading and MOSFET reading were 
acquired simultaneously. 
 
Point doses of the TomoTherapy plans were measured at the phantom surface and under 
5 mm bolus. TomoTherapy and tangential-beam chest wall plans on the Rando phantom 
were delivered on a TomoTherapy unit and an Oncor linear accelerator respectively.  
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Treatment plans for a TomoTherapy® delivery quality assurance (DQA) phantom, 
known as cheese phantom, were also generated for this study. The cheese phantom was 
used because of the convenience of using a ready-pack film to measure the dose 
distribution including the “skin” dose. Kodak extended dose range (EDR) films were 
used to measure the skin dose gradient relatively. Figure 15 shows the measurement setup 
with film and MOSFET dosimeters. A Hurter and Driffield (H & D) curve was generated 
for this purpose. The exposed EDR film was scanned and the dose distribution image was 
analyzed on the TomoTherapy® planning system. The measured dose distribution was 
aligned with the planar dose distribution from the plan using the alignment tools in the 
planning system. 
 
 
 
Figure 15.  Film and MOSFET dose measurement setup with TomoTherapy cheese 
phantom.  Treatment plans were generated to simulate chest wall treatment. The treating 
region was along the edge of the phantom where MOSFET dosimeters were located.  
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Figure 16.  Dose gradient difference between the film measurement and the treatment 
plan. The real dose increases with depth much faster than that in the plan. Due to this 
difference and the coarse resolution in TomoTherapy treatment plans, a slight difference 
in phantom edge definition could cause a large range of dose variation between 
measurements and plans. In this figure, the difference between line a and d is about 2 
mm, while the dose difference of the planned dose-measured dose ranges from -0.1 to 
+0.4 Gy. 
 
3.4  Results  
 
3.4.1  Film Dosimetry  
 
The relative dose distributions measured using EDR film on the cheese phantom for chest 
wall treatment plans showed steeper dose gradient than that in TomoTherapy plans. 
Figure 16 is an example of the comparisons of the dose gradients between the planned 
and measured dose distributions. In this example, the shallow dose increased from 1.5 to 
2.0 Gy in 2 mm depth. Due to the coarse spatial resolution in TomoTherapy planning 
system, one pixel misalignment between the film and the phantom image could introduce 
2 mm spatial shift. If this spatial shift is along the high gradient direction, it corresponds 
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to a 0.5 Gy difference in superficial dose. The dose gradient difference between the film 
measurements and TomoTherapy plans could be the explanation to the wide variation of 
superficial dose differences reported by different groups(26-28) (see Figure 16). Also 
because of this difference, TomoTherapy planning is likely to overestimate the superficial 
dose. An important conclusion of the film dosimetry study is that the TomoTherapy 
planning may overestimate the superficial dose while it underestimates the dose gradient 
in shallow regions in chest wall treatment plans. In the example shown in Figure 16, the 
dose gradient of the measured dose is two times that of the planned dose in the high 
gradient region. The sharp dose gradient in chest wall treatment may cause higher skin 
dose (not superficial dose) than what the plan shows. 
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Figure 17.  (A) Monte Carlo calculated TomoTherapy percentage depth dose (PDD) 
versus measured PDD. The SSD is 85 cm; (B) Monte Carlo calculated shallow depth 
dose distributions of a TomoTherapy machine and a conventional linear accelerator 
versus SSD and incident angle. The statistical uncertainty of the Monte Carlo calculated 
PDD is within 1% for all data points (see the error bars). 
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Table 1.  Comparison of the measured superficial dose between TomoTherapy and 
tangential-beam techniques on a Rando phantom using MOSFET.  
 
Technique TomoTherapy Tangential-beam 
Location Surface 5mm bolus Alternative Surface 5mm bolus Alternative 
Dose (cGy) 152.4±6.1 205.6±9.7 179.0±5.7 134.0±8.0 188.5±5.5 161.3±4.9 
% to 2 Gy 76.2±3.0 102.8±4.8 89.5±2.9 67.0±4.0 94.3±2.8 80.6±2.4 
 
 
3.4.2  MOSFET Dose Measurement 
 
The calibration of MOSFET against ion chamber was carried out using a TomoTherapy 
unit in stationary mode. The MOSFET readings differed with ion chamber readings by -
1.51% ± 0.44%, within the manufacturer’s specification. 
 
Table 1 lists the measured point doses at phantom surface and under 5 mm bolus. The 
average dose of alternative bolus on/off was calculated using the measured doses. The 
measured superficial dose of the TomoTherapy plan (76.2% ± 3.0% of the prescribed 
PTV dose) is lower than the alternative bolus on/off dose of the tangential-beam 
technique (80.6% ± 2.4%) but comparable, while the alternative on/off dose from the 
TomoTherapy plan (89.5% ± 2.9%) is also within the adequate dose range. Considering 
the skin dose is actually not the superficial dose but at about 1 mm depth, and the sharp 
dose gradient in the shallow regions, this dose could be too high and likely to cause skin 
reactions. 
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3.4.3  Monte Carlo Study 
 
Figure 17A shows the agreement of the measured and calculated PDD curves for the 
TomoTherapy machine. Figure 17B demonstrates the dose differences at shallow depth 
versus SSD and accelerator. The effect of the 15 cm difference in SAD between 
TomoTherapy and conventional accelerator can be seen in this figure. About 2% 
difference in dose is introduced by the SAD difference, with a higher superficial dose for 
a shorter SAD (the superficial dose difference between curves 1 and 4 in Figure 17B). 
The absence of the flattening filter increases the superficial dose by about 7% at the same 
SSD (Curves 3 and 4). The combination of the absence of a flattening filter and shorter 
SSD results in about an 8% higher superficial dose for TomoTherapy (Curves 1 and 3).  
 
Tangential beams increase the superficial dose for both TomoTherapy beams and 
conventional accelerator beams. The Monte Carlo simulation shows that the magnitude of 
the increase is about the same for both TomoTherapy beams and conventional accelerator 
beams (Curve 2 versus Curve 1 for TomoTherapy beams and Curve 5 versus Curve 3 for 
conventional accelerator beams in Figure 17B). A 17% superficial dose increase can be 
observed in Figure 17B when the incident angle is changed from 0 to 60 degrees. 
 
The shallower dmax in TomoTherapy beams with large incident angles is the major reason 
that the TomoTherapy chest wall treatment plans usually have higher skin dose than 
conventional tangential-beam plans. 
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3.4.4  Plan Analysis and Comparison 
 
Figure 18 shows the skin dose comparison of a TomoTherapy plan without bolus to 
tangential-beam plans of with and without bolus. The same patient and same location was 
chosen for all the depth dose profiles of the TomoTherapy and tangential-beam plans. 
The superficial dose of the TomoTherapy plan was much higher than the average of the 
two tangential-beam plans. While Figure 17 shows the comparison for only one location, 
Table 2 lists more statistical data of the comparison, which shows even higher skin dose 
without bolus and less dose variation in the TomoTherapy plans compared to the 
conventional tangential-beam plans. Comparing the superficial doses listed in Table 2 
with the ones in Table 1 which are the measurement data, an overestimation of superficial 
dose in TomoTherapy plans of about 12% can be concluded, while for the tangential 
plans, the overestimation is about 2%. Taking into account the overestimation of 
superficial dose by TomoTherapy, in the example shown in Figure 18, even without 
bolus, the corrected TomoTherapy plan (about 80% superficial dose) still provides 
adequate skin coverage, which agrees with the measurement data in Table 1 within 4%.  
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Figure 18.  Skin dose comparison of TomoTherapy with tangential-beam technique.  All 
dose profiles were obtained from treatment plans of the same left sided chest wall patient 
at the same location. The superficial dose of the TomoTherapy plan (without bolus) is 
between the ones of tangential plans with and without bolus.  
 
Table 2.  Normalized dose at the surface, 2 and 5 mm depth is compared for chest wall 
treatment plans using the tangential-beam technique and TomoTherapy. Dose at the 
surface and depth are normalized to the prescribed dose. A total of 20 points in treatment 
plans were chosen for each depth. The value shown in this table for each plan at each 
depth is the average and one standard deviation. Even without bolus, TomoTherapy plans 
usually have high superficial dose and dose at shallow depth (skin dose). The standard 
deviation in TomoTherapy plans is usually smaller than that in conventional tangential-
beam plans, indicating more conformal dose distributions in TomoTherapy plans. The 
overestimation of superficial dose in the plans is not corrected in this table. 
 
Plan % superficial dose % dose @2mm % dose @5mm 
Tangential, no bolus 69 ± 6 85 ± 5 97 ± 3 
Tangential, bolus 83 ± 7 87 ± 4 95 ± 2 
TomoTherapy , no bolus 88 ± 3 92 ± 4 94 ± 4 
TomoTherapy , bolus 102 ± 3 104 ± 2 101 ± 2 
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3.4.4.1  Discussion 
 
A possible problem associated with bolus is that there may exist air gaps between the 
bolus and chest wall (Figure 14) which could further vary in daily treatments. This 
variation would introduce uncertainty in delivered dose. Especially for TomoTherapy, the 
variation of daily bolus location could introduce dose uncertainty due to its helical 
delivery technique. However, bolus has been suggested as desirable for TomoTherapy to 
reduce the effect of daily setup error and potential underdosing of the surface(36), and to 
correct for shallow depth dose overestimation in TomoTherapy treatment planning 
algorithm(26). 
 
Due to the angular dependence of MOSFET dosimeters (3.0-3.5%), their measurement 
uncertainties (2-3%) and other possible setup errors, the estimated accuracy of MOSFET 
dosimetry is about ± 6%(37). The estimated 12% overestimation of TomoTherapy 
treatment planning system may include the MOSFET measurement uncertainty.  
 
Based on the measurement data, TomoTherapy without bolus delivers adequate skin dose 
but it is lower than what the alternative bolus on/off plan of tangential-beam technique 
delivers (76.2% ± 3.0% of prescribed PTV dose versus 80.6% ± 2.4% to skin surface). 
TomoTherapy alternative plan also delivers adequate skin dose (89.5% ± 2.9% to skin 
surface) but at the high limit. A scheme of two days without bolus and one day with bolus 
in TomoTherapy gives a moderate superficial dose (85.1% ± 2.6%). 
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3.5  Conclusion 
 
Compared to a tangential-field technique, TomoTherapy shows a higher superficial dose 
in chest wall treatment without using bolus in both treatment plans and measurements. 
The reasons of the higher superficial dose are 1) slightly lower mean energy than a 
conventional linear accelerator and therefore a shallower dmax, 2) shallow delivery angles 
used in the treatment delivery, and 3), the smaller SAD of the TomoTherapy unit. 
Therefore it is a reasonable clinical practice to treat chest wall on TomoTherapy without 
using bolus, or using a modified bolus on/off scheme (two days off, one day on).  
53 
 
 
 
CHAPTER 4  PAPER II:  COMPENSATOR-BASED INTENSITY-MODULATED 
RADIATION THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA 
POST-EXTRAPLEURAL PNEUMONECTOMY 
 
This chapter investigates the potential of compensator-based intensity-modulated 
radiation therapy (CB-IMRT) as an alternative to multileaf collimator (MLC)–based 
intensity-modulated radiation therapy (IMRT) to treat malignant pleural mesothelioma 
(MPM) post-extrapleural pneumonectomy. This study points out the challenges in 
planning and delivery of large fields on a specific linear accelerator with MLC. The study 
focuses on producing dosimetrically acceptable and deliverable IMRT plans for treating 
large modulated fields with solid modulator and step and shoot MLC. These plans are 
also calculated on a phantom for the quality assurance test of absolute point dose and 
relative dose distributions.  
(J Appl Clin Med Phys. 2008 Oct. 29; 9(4): 98-109) 
 
4.1  Synopsis 
 
Treatment plans for four right-sided and one left-sided MPM post-surgery cases were 
generated using a commercial treatment planning system, XIO/CMS (Computerized 
Medical Systems, St. Louis, MO). We used a 7-gantry-angle arrangement with 6MV 
beams to generate these plans. The maximum required field size was 30x40 cm2. We 
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evaluated IMRT plans with brass compensators (●Decimal, Sanford, FL) by examining 
isodose distributions, dose–volume histograms, metrics to quantify conformal plan 
quality, and homogeneity. Quality assurance was performed for one of the compensator 
plans. 
 
Conformal dose distributions were achieved with CB-IMRT for all 5 cases, the average 
planning target volume (PTV) coverage being 95.1% of the PTV volume receiving the 
full prescription dose. The average lung V20 (volume of lung receiving 20 Gy) was 1.8%, 
the mean lung dose was 6.7 Gy, and the average contralateral kidney V15 was 0.6%. The 
average liver dose V30 was 34.0% for the right-sided cases and 10% for the left-sided 
case. The average number of monitor units (MUs) per fraction was 980 MU for the 45-
Gy prescriptions (mean: 50 Gy) and 1083 MU for the 50-Gy prescriptions (mean: 54 Gy). 
 
Post-surgery, CB-IMRT for MPM is a feasible IMRT technique treated with a single 
isocenter. Compensator plans achieved dose objectives and were safely delivered on a 
Siemens Oncor machine (Siemens Medical Solutions, Malvern, PA). These plans showed 
acceptably conformal dose distributions confirmed by multiple measurement techniques. 
Not all linear accelerators can deliver large-field MLC-based IMRT, but most can deliver 
a maximum conformal field of 40x40 cm2. It is possible and reasonable to deliver IMRT 
with compensators for fields this size with most conventional linear accelerators. 
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The future work will address the skin dose of compensator-based IMRT treatments. 
 
Key words: malignant pleural mesothelioma, compensator-based IMRT, SMLC IMRT, 
plan conformality, quality assurance 
 
4.2 Introduction 
 
Treating malignant pleural mesothelioma (MPM) post-surgery requires very large fields. 
This paper addresses intensity-modulated radiation therapy (IMRT) plans with solid 
modulators for the large fields required to treat MPM post-surgery, given that these plans 
first closely achieved the prescription dose objectives, passed the quality assurance (QA), 
and were safely delivered. 
 
Malignant pleural mesothelioma is a fatal aggressive cancer of the pleura and a large 
complex target volume. Reports show that the incidence of the disease is increasing 
globally, with 2000 new cases annually in the United States(38).  Increased incidence of 
mesothelioma is strongly associated with exposure to asbestos, which is most commonly 
used in Western industrial societies; more men than women are affected(39).  In 2003, the 
Surveillance, Epidemiology, and End Results Program of the U.S. National Cancer 
Institute projected the total number of MPM cases in American men to be approximately 
71,000 by the year 2054(40).  Because of the predicted numbers of new cases, the National 
Cancer Institute is sponsoring clinical trials designed to seek new treatment modalities. 
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Traditionally, radiation therapy treatment techniques used external beam radiation with a 
combination of photon and electron beams(41, 42) and intraoperative brachytherapy with 
post-operative mixed photon irradiation(43). Normal tissue was spared using photon and 
electron blocks for external beam treatments. Various dose regimens have been 
prescribed for palliation and local control of this disease, ranging from 30 Gy(44) to a 
median dose of 36 Gy(45) (palliation) and 54 Gy (45 – 54 Gy, local control)(46) 
administered to the hemithorax. The latter treatment showed improved local control with 
acceptable toxicity. This finding seems to demonstrate that a sufficient dose was achieved 
for palliation and local control of the disease with the conventional techniques. Published 
literature lacks metrics, including dose–volume histograms (DVHs), which have 
increasingly become a crucial part of plan review, and comparisons complementing 
isodose distribution in transverse and orthogonal planes. Radiation oncologists often use 
information from computed tomography (CT), magnetic resonance, and positron-
emission tomography imaging to accurately delineate the target and organs-at-risk (OAR) 
volumes so as to prescribe and quantify the dose to these sensitive overlapping structures. 
The use of IMRT allowed for further dose escalation to large target volumes while 
maintaining tolerance doses to abutting radiation-sensitive structures(47). Post-operative 
IMRT for MPM has shown the most promising early local control of this disease(48-50). 
Current techniques often couple IMRT from a specific treatment planning system with 
specific beam delivery and verify systems. Stevens et al.(67) found that Corvus, Pinnacle, 
and Eclipse treatment planning systems were all capable of generating acceptable IMRT 
plans for MPM after extrapleural pneumonectomy (EPP). The authors compared 
treatment planning systems and found that the early plans with Corvus had the largest 
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number of monitor units (2786 MUs) and segments (1050 segments), and that a newer 
version of Eclipse had the least number of MUs (1813 MUs) and segments (173 
segments). 
 
Delivery of large IMRT fields with a multileaf collimator (MLC) is limited by MLC 
designs(51). For example, the Siemens Oncor machine (Siemens Medical Solutions, 
Malvern, PA) with 82-leaf Optifocus MLC system allows for a maximum IMRT field 
size of 22x40 cm2. The MLC carriage-over-travel distance past the central axis is limited 
to 10 cm. Even though a field size of 24x40 cm2 can be accommodated, given that the 
smallest segment size can be set to 2x2 cm2, larger IMRT field widths are required to 
treat MPM. To overcome the MLC field size limitations, treatments with multiple 
isocenters have been proposed by other investigators(19). We investigated a compensator-
based IMRT (CB-IMRT) technique with a single isocenter to treat MPM post-surgery. 
 
It is essential that the modulator (MLC or solid brass compensator) reproduce the 
intended fluence map. For three of four right-sided cases, a number of IMRT fields 
required a minimum field width of 26 cm. These cases were good candidates for CB-
IMRT delivery (which has no IMRT field size limit, and for which a maximum 
conformal field size of up to 40x40 cm2 is possible) on the Siemens Oncor machine. 
Intensity-modulated radiation therapy with compensators has been successfully used for 
more than a decade(52,53). The CB-IMRT technique offers continuous intensity 
modulation. Compensators deliver the intensity-modulated dose in static form to all 
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points within a field relatively instantaneously where the beam-on time depends on the 
machine dose rate. 
 
To investigate the potential of very large field CB-IMRT for MPM, the goal was to create 
plans that closely achieved the prescription dose objectives for MPM post-surgery and 
that produced manageable modulators that were delivered on our Siemens Oncor 
treatment machine. 
 
4.3  Materials and Methods 
 
All data sets acquired for this test study came from patients who underwent surgery 
before simulation. 
 
4.3.1  Surgery 
 
The EPP procedure involves removal of the ipsilateral lung (remove motion) and hemi-
diaphragm resection, with subsequent reconstruction using polytetrafluoroethylene fabric. 
A mediastinal lymph nodes dissection is also performed, as is a chest wall resection and 
reconstruction. To assist the radiation oncologist with the contouring, the surgeons place 
clips to identify the entire outline of the resected hemi-diaphragm and the resected 
margins. These areas are otherwise difficult to identify post-operatively. The simulation 
for treatment planning occurs 6 – 8 weeks post-surgery. 
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4.3.2  Simulation 
 
Surgical scars were typically wired and then covered with bolus (7 cm wide, 0.50 cm 
thick) extended 4 cm proximally and distally over the scar. Patients were immobilized 
supine on the CT couch using a wing board (Med-Tec, Orange City, IA) in combination 
with a vacuum bag and the T-bar system indexed to the couch top. The T-bar helps 
support the arms up and out of the radiation field. Radio-opaque ball bearing markers 
were taped to the anterior and lateral sides of the patient for treatment planning and as a 
setup reference. 
 
Simulation CT slice thicknesses were typically 5 mm (no larger). At least 100 transverse 
slices were acquired and transferred to the treatment planning system. 
 
4.3.3  Contours 
 
The use of IMRT required contouring of the clinical target volumes (CTVs), which 
included the tumor bed (post EPP) and the regions at risk for seeding of disease. The 
CTV extended from T1–L3 (from apex of thorax to inferior pole of kidney). The contours 
for the contralateral lung, kidneys, heart, liver, esophagus, small intestine, spinal cord, 
and skin were drawn on every slice (a time-consuming process). The three dimensional 
auto margin functions were used to create a PTV0.5 cord (CTV + 0.5 cm) and cord 
avoidance (cord + 0.5 cm) structure. Avoidance and boost structures were drawn 
manually. To account for uncertainties in contouring the CTV, superior and inferior 
60 
 
margins were set 1 cm above and 1 cm below the most superior and most inferior surgical 
clips. The anterior, posterior, and lateral margins were defined by adding 0.75 cm to 
violated spaces clipped at the skin. 
 
4.3.4  Treatment Planning 
 
Coplanar IMRT beams (6MV) aimed at the center of the planning target volume (PTV) 
were designed. The first gantry angle was 180 degrees, and the remaining 6 angles were 
at about 30- to 45-degree intervals, excluding the anterior–posterior field. These were 
selected using a beam’s eye view tool to minimize entrance and limit exit doses to 
contralateral lung. Gantry angles were adjusted as much as possible while obtaining the 
desired dose distributions. We noticed that liver position varied in the superior–inferior 
direction with respect to CTV position for these cases. Planning right-sided cases with 
sufficient CTV coverage, given the extent of liver in the radiation field, was more 
challenging because of the competing dose constraints of these structures. 
 
4.3.5  IMRT Plans 
 
Seven fields (gantry angles), A – G, were selected to conform to PTV using MLC. Fields 
A – D were split to keep the compensator weights manageable, resulting in additional 
fields A1 – D1. Fields A and A1 were split in the inferior–superior direction with at least 
a 2 cm overlap margin. The PTV contour seen by each field was also edited and MLC 
conformed to the new split contour shapes. The same procedure was repeated for fields 
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that needed to be split. The fields were split at varying distances from central axis to help 
reduce possible high dose at the junction area. 
 
4.3.6  IMRT Prescription Page 
 
Target and OARs were set up in the IMRT prescription page according to the prescription 
guidelines shown in Table 3. Deviation from goal doses for the minimum and the 
maximum PTV coverage was given the highest penalties. Liver, kidneys, contralateral 
lung, and heart were given higher overlap priorities than were the other OARs. Maximum 
dose to the liver was set to the maximum PTV dose with relaxed penalty, but certain 
percentages of liver and contralateral lung volumes were restricted to very low doses with 
very high penalties. The point was to achieve the suggested prescription dose objectives 
to these structures. 
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Table 3.  Dose–volume guidelines for the target and organs at risk (OARs)a. 
 
Target or OAR Dose–volume guideline 
Clinical target volume V100 > 98% 
Planning target volume V100 > 95% 
Contralateral lung V20 < 4% 
Mean lung dose 6–8 Gy or ALARA 
Spinal cord Less than 10% > 45 Gy 
 0.0% > 50 Gy 
Heart V45 < 50% 
Liver V30 < 30% or ALARA 
Right kidney V15 < 20% 
Left kidney V15 < 20% 
Esophagus V55 < 30% 
 
a, The planning target volume is the clinical target volume plus 0.5 cm. The V100 is the volume 
receiving 100% of the prescribed dose. Contralateral lung V20 is the volume of lung receiving 20 
Gy. Lung mean lung dose and liver V30 are kept as low as reasonably achievable (ALARA). 
 
4.3.7  Compensator Plans 
 
4.3.8  Treatment Planning Strategy 
 
Our CB-IMRT plan strategy process started with an arrangement of 5 non-coplanar fields 
for the left-sided case and arrangements of 7 coplanar fields for the right-sided cases, 
which resulted in acceptable dose distributions but very heavy modulators (weight up to 
15.9 kg). An 11.3-kg compensator from the 7-field arrangement is shown in Figure 19. 
These large fields were then split, which resulted in 7-gantry 14-coplanar fields with field 
junction overlap matched at the central axis, using modulators 7.62 cm thick that yielded 
acceptable dose distributions with 125% hot spots in the junction area. The average 
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compensator weight was 8.2 kg (range: 6.3 – 9.1 kg). We did not achieve the plan 
objectives if all beams were modulated with the brass modulators (5.08 cm maximum 
thickness), even with the MLC blocking. The outcome was a 7-gantry 11-coplanar field 
arrangement with modulators (5.08 cm and 7.62 cm maximum thickness) and field 
junction overlap at varying distance from the central axis. The median compensator 
weight was 7.5 kg (5.2 – 10.0 kg). 
 
All CB-IMRT plans were generated using an MLC blocking that conformed the beam to 
the PTV plus a 0.5 cm block margin. We found it desirable to plan the compensator fields 
with MLC blocking advantages. In addition, individual MLC leaves can be edited to 
further enhance the distribution even after the compensators are generated. The effective 
attenuation coefficient (EAC) values were assigned for all fields. We used compensators 
(7.62 cm maximum thickness) with an intensity modulation range of 8% – 100% for 
fields that contained significant parts of the contralateral lung or liver. These large fields 
would produce heavy modulators, and thus were divided. We used compensators (5.08 
cm maximum thickness) with an intensity modulation range of 20% – 100% for fields 
that contained no significant parts of lung or liver. The only lung had to be spared. We 
tried to keep the 10-Gy isodose line outside the contralateral lung and kidney volumes to 
maintain prescription guidelines to these structures. All IMRT plans were calculated 
using superposition with heterogeneity corrections applied.  
 
Dose distributions and DVHs were reviewed by the radiation oncologist. Each field was 
set up in the IMPAC Record and Verify system (IMPAC Medical Systems, Sunnyvale, 
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CA) with its unique accessory tray code (S2N01–S2N18). Two coded trays are shown in 
Figure 19.  Compensator thickness files were electronically sent to ●Decimal for 
fabrication; the modulators were returned within 24 hours. 
 
 
 
Figure 19.  Two modulators from ●Decimal mounted on the Siemens coded trays. One of 
the large compensators (11.3 kg) from the initial 7-field plan that did not require 
extensive blocking within the field is shown next to one of the 7-field IMRT modulators 
for prostate (1.8 kg). 
 
 
4.3.9  Compensator Thickness File 
 
The brass thickness t (i,j) can be calculated as a simple exponential attenuation equation 
for an array of values each representing the filter thickness for each ray line at (i, j) as in 
equation 2: 
 
( ) ( )[ ]
eff
jitransjit μ
,ln, −=  (2) 
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where Trans(i, j) is the transmission for each ray line throughout the compensator and µeff 
is the EAC for solid brass compensator under broad-beam geometry. du Plessis et al.(54) 
showed that the absorbed dose varies exponentially as a function of absorber thickness on 
the beam axis at any depth in water for any material. These authors showed that EAC for 
brass can vary by as much as 13% over a depth range of 4 – 39 cm. The measurement 
showed that EAC values decreased with increasing field size, depth, and thickness as 
beam hardening and more scatter for larger field sizes contributed to dose at the given 
depth. 
 
Beam divergence and beam hardening is taken into account by the treatment planning 
system dose computation. Mean energy of the beam increases after the beam passes 
through the modulator.  Jiang and Ayyangar(55) showed that beam hardening resulted in 
greater change (sparing) in surface dose than in dose at depth with respect to maximum 
dose. Authors showed that for a 6MV 10x10 cm2 beam, a 10% maximum dose reduction 
occurred in surface dose and a 3% dose increase occurred in percent depth dose at 10 cm 
depth for Cerrobend slab 5 cm thick (p = 9.76 g/cm3). 
 
4.4  Safety Considerations 
 
We considered limiting the maximum compensator weight to a level that therapists were 
comfortable with in safely handling the device. We had the therapists try the 10 kg and 
15.9 kg compensators. The therapists who could easily handle the 45-degree solid wedge 
(which is 6.1 kg) were able to insert the 10 kg modulators into the wedge slot with ease; 
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the 15.9 kg modulators posed more of challenge for most of the therapists. The 
manufacturer’s recommended weight limit for the Siemens Oncor block tray accessory is 
15.9 kg; however, we do not have the weight limit information for the wedge tray slot 
accessory. We tried to exercise safety in handling the relatively heavy modulators. 
 
Modulators were loaded with the gantry set at 90 degrees or 270 degrees. The delivery 
was such that no loaded compensator field crossed over the patient at any time, and for 
patient safety, plans were designed without the anterior–posterior field. 
 
4.4.1  Plan Evaluation 
 
We used two-dimensional isodose distributions (axial, sagittal, and coronal planes) to 
visually inspect the target coverage. Quantitative techniques such as DVH analysis and 
other indices were used to evaluate the plans. Table 4 shows the fraction of PTV volume 
receiving 100% of the prescribed dose in grays (PTV V100); high dose in grays to 5% of 
PTV volume (PTV D05); conformation number (CN), an index proposed by van’t Riet et 
al.(56) , which takes into account the quality of coverage of the target and the volume of 
healthy tissue receiving at least the prescribed dose; and the homogeneity index (HI) as 
the ratio between maximum dose and prescription dose within the target. In addition, 
contralateral lung V20, V5, and mean lung dose (MLD); V30 for liver; V45 and V50 for 
heart; V15 for contralateral kidney; and maximum cord dose and dose to 10% of cord 
(D10) were used to score OAR protection. Treatment efficacy with compensators in terms 
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of MUs per field, total MUs, and beam-on time per daily fraction and per total treatment 
time are reported. 
 
4.4.2  Quality Assurance 
 
We used multiple measurement techniques to perform IMRT QA. Dose distributions for 
one of the compensator plans were recalculated for three QA phantoms. This repetition 
provided the reference for comparison with absolute point dosimetry measurement using 
a calibrated ion chamber, single coronal field using absolute dose distributions 
measurement with the Map Check diode array device (Sun Nuclear Corporation, 
Melbourne, FL), and composite dose distributions at 4 transverse film planes irradiated 
simultaneously with true gantry angles incident on the phantom. We registered extended 
dose range (EDR2) films to the plan and analyzed them using the RIT 113 film dosimetry 
system (RIT Inc., Denver, CO). 
 
4.5  Results 
 
Figure 14 (a–d) shows isodose distributions for right-sided and left-sided cases. Notice 
that the 10-Gy isodose line is kept outside the contralateral lung. Figure 14 (a,b) shows 
dose distributions in the coronal and sagittal planes, and dose profile at various distances 
from the central axis in those planes. Figure 14 (a) shows the coronal dose distributions 
for the right-sided case. The flat dose profiles show that dose varies 2% across the 
coronal plane and 6% along the plane.  Figure 14 (b) shows the dose distributions for the 
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right-sided case in the sagittal plane. The profile throughout the field junction shows 
118% hot spots.  Figure 14 (c) shows the 50-Gy prescription dose distributions for the 
right-sided case. Figure 14 (d) shows the dose distributions for the left-sided case. Figure 
15 (a,b) shows DVHs for one of the right-sided and the left-sided MPM case. 
  
(a)(b) 
 
(c)(d) 
 
Figure 20.  Dose distributions and profiles in the coronal and sagittal planes. (a) Sagittal 
profile of a right-sided case shows the profiles across the coronal plane at isocenter, ±2 
cm from isocenter, and 6 cm inferior and 12 cm superior to isocenter. The profile 6 cm 
inferior to isocenter shows the degree of liver-sparing in this plane. (b) Coronal profile of 
a right-sided case shows the profiles at isocenter, ± 2 cm from isocenter, and 5 cm 
posterior and 8 cm anterior to isocenter plane. (d) Dose distribution for the left-sided case 
is shown.  
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All plans conformed to 99.2% of CTV volume and 95.5% of PTV volume achieving the 
prescription dose. Lung V20 was less than 2%, and MLD ranged between 5 Gy and 8 Gy 
for all plans. All lung MLDs and V5s were below the range at which pneumonitis was no 
longer reported to have been observed by other investigators(57). The average value for 
liver V30 was 34%. 
 
To compare IMRT treatment parameters with segmented MLC (SMLC) and compensator 
delivery on the Siemens machine, we used the same field configuration in planning 2 
cases with SMLC IMRT. Large optimized fluence had to be segmented with a minimum 
MLC segment size greater than 2 cm2 (because of IMRT field size limitations) to produce 
deliverable plans. More desirable and better dose delivery resolution was not possible in 
this case. In Table 4, note that (TVRI/VRI) is worst for plan 5 with MLC (5LM). As 
compared with compensator plan 5LC, this plan shows more non-target tissue receiving 
the prescription dose.  
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(a) 
 
(b) 
 
 
Figure 21.  Dose–volume histograms for the planning target volume (PTV), clinical target 
volume (CTV), and the liver, lung, kidneys, and spinal cord for (a) a right-sided case, and 
(b) the left-sided case. 
 
One possible explanation may be that plan 5LM needed to have a smaller segment size, 
and thus higher dose sculpting power, to block portions that needed to receive less dose. 
This plan also had higher HI than did the compensator plan. Table 4 also shows MLC 
parameters such as total number of segments and MUs, and total treatment time. Total 
number of MUs was 1993 MUs with 244 segments for plan 1RM (Table 4). Treatment 
time per beam can be seen to be significantly shorter for compensators. The total number 
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of MUs was doubled for SMLC. Total treatment time was slightly shorter for 
compensator delivery, and yet comparable with automated SMLC delivery as shown in 
Table 3. 
 
Table 3 shows the number of MUs for the 5 compensator and 2 MLC plans. Our plans for 
4 right-sided and 1 left-sided case resulted in an average of 980 MU (range: 882 – 1040 
MU) per daily fraction. The average daily delivery time was 33 minutes, which included 
entering the room to check the isocenter and to replace the compensators for all fields. 
 
Table 4.  Plan valuesa. 
 
Plan PTV PTV (TVRI/TV) (TVRI/VRI) CN HI 
ID V100 (%) D05 (Gy)     
1RC 95 52 0.95 0.96 0.92 1.3 
1RM 95 55 0.95 0.96 0.91 1.4 
2RC 95 54 0.95 0.82 0.78 1.5 
3RC 95 54 0.95 0.90 0.86 1.2 
4RC 95 56 0.95 0.93 0.88 1.2 
5LC 97 52 0.97 0.85 0.83 1.2 
5LM 98 55 0.98 0.81 0.80 1.5 
 
a.Plan 1RC (plan 1, right-sided case, with compensators) shows that 95% of the planning target 
volume (PTV) received 100% (V100) of the prescribed dose of 45 Gy. The high dose to 5% of the 
PTV volume is 52 Gy for the compensator plan and 55 Gy for the multileaf collimator (MLC) 
plan 1RM (plan1, right-sided case, with MLC). 
PTV = planning target volume; TV = target volume; RI = reference isodose line; CN = 
conformation number; HI = homogeneity index; V100 = volume receiving 100% of the prescribed 
dose; D05 = high dose to 5% of the volume; plan ID key: plan number (1 – 5), right- or left-sided 
(R, L), compensator or multileaf collimator (C, M). 
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Table 5.  Plan delivery valuesa. 
 
Plan Average Total Segments Average Total 
ID MUs MUs  beam-on time treatment 
 per field   per field time 
    (s) (min) 
1RC 89 976 — 18 33 
1RCb 98 1083 — 23 34 
1RM 181 1993 244 198 36 
2RC 87 962 — 18 33 
3RC 94 1040 — 19 35 
4RC 97 1039 — 19 35 
Avg. RC 92 1004 — 18.5 34 
5LC 80 882 — 16 30 
5LM 164 1801 193 126 35 
 
a.The average beam-on time per field for compensator plans 1RC – 4RC and 5LC was calculated 
based on 300 cGy/MU at the central axis. The number of segments are shown for the multileaf 
collimator plans 1RM and 5LM. Total treatment time for compensator delivery includes entering 
the treatment room to replace the compensator for each field. Plan ID key: plan number (1 – 5), 
right- or left-sided (R, L), compensator or multileaf collimator (C, M). 
b.For 50 Gy prescription dose. 
 
 
4.5.1  QA Results 
 
The measured absolute dose in water and in cube phantom for the composite plan agreed 
within 3% of the calculated dose. Figure 16 (a) shows one of the individual fluence maps 
from Map Check. At least 95% of the measured and calculated isodose distributions were 
found to be in agreement within 3% and 3 mm distance to agreement for all individual 
compensator fields. The large EDR2 film dosimetry showed 117% hot spots in the 
junction area, consistent with the predicted value. Figure 16 (b) shows the QA results 
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using the cube phantom. The measured orthogonal profiles were extracted, which showed 
good agreement with the calculated profiles. 
 
(a) 
 
(b) 
 
 
Figure 22.  The calculated and measured isodose distributions in the coronal plane for 
one of the compensator fields is shown in the top right and top left quadrants. At the 
bottom left, the overlaid absolute dose distributions are seen. Overlaid oblique profiles 
are shown in the bottom right quadrant. DTA = distance to agreement. (b) The cube 
phantom is shown at the lower left. The RIT film dosimetry system (RIT Inc., Denver, 
CO) analysis window shows good agreement between the measured and calculated dose 
distribution. 
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4.6  Discussion 
 
Although the words “compensator” and “solid modulator” were used interchangeably 
throughout this chapter, the intention was to refer to the same device that modifies the 
intensity of the beam. The goal of the present study was to devise a CB-IMRT technique 
for MPM post-surgery that met the prescription objectives and could be safely delivered. 
The results reported here are based on the reference dose of 45 Gy. We also tested the 
technique for a higher prescription dose. We found that the results also apply to the 
prescription dose of 50 Gy. We re-optimized plan 1RC (plan1, right-sided case, with 
compensators) for a higher prescription dose of 50 Gy. Figure 14 (c) shows the dose 
distribution. We achieved the prescription objectives with at least 95% of the PTV 
volume receiving 50 Gy, with a mean dose of 54 Gy. Liver V30 was less than 36%, 
contralateral lung MLD and V20 were 5.7 Gy and 1% respectively. No portion of cord 
received 50 Gy. The total number of MUs for the 50-Gy plan for the right-sided case was 
1083 MU. 
 
We used conformity number as one of the metrics to quantify conformal plan quality. 
The conformity number is defined in equation 3. We calculated the DVHs for all tissue 
and non-tissue (unspecified tissue not contoured). The target volume covered by the 
reference isodose line, TVRI, was calculated. The first term in equation 3 takes account 
only of quality of target coverage. This value for right-sided plans was 0.95 for 
compensator plans (as in Table 4). The second term describes the ratio of the PTV 
volume that received the prescription dose to the volume of the reference isodose line. 
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All non-target tissue and non-tissue volume covered by the reference isodose line was 
summed. The average value for the 4 right-sided cases was 0.90 for compensator plans 
and 7.2% of non-target tissue for right-sided cases. For left-sided case with 
compensators, 12.3% received the prescription dose. If the CN value is 1, the target 
conformity is 100% and the dose must fall rapidly outside the large PTV. As indicated 
earlier, part of the liver and kidney volumes fell inside the PTV because of overlap. In 
fact, about 10% of liver volume received the reference dose. 
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4.7  Conclusions 
 
We found that CB-IMRT with 7 gantry angles produced dosimetrically acceptable plans 
for a single isocenter, without the need to match electron fields; however, it produced 
heavy modulators. The same gantry angles with 11 coplanar 6MV IMRT fields produced 
acceptable conformal plans and closely achieved the prescription dose objectives. The 
resulting modulators with an equivalent field size of 26 cm2 were easier to manage. Total 
treatment time for manual CB-IMRT delivery was comparable with automated SMLC 
delivery. For MPM, CB-IMRT showed acceptably conformal dose distributions 
confirmed by multiple measurement techniques. Not all linear accelerators can deliver 
large-field SMLC-based IMRT with a single isocenter, but most can deliver a maximum 
conformal field size up to 40x40 cm2. It is possible and reasonable to deliver IMRT with 
compensators for fields this size with most conventional linear accelerators. IMRT with 
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solid modulators adds an additional option to existing linear accelerators (LINACs) to 
treat large target volumes, as was the case for MPM post EPP. 
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CHAPTER 5  PAPER III:  6MV BUILDUP DOSE FOR COMPENSATOR-BASED 
IMRT COMPARED TO MLC-BASED IMRT 
 
Dose in the buildup region was investigated for intensity-modulated radiation therapy 
(IMRT) delivery with solid brass modulator and MLC. A Varian Clinac 2100 linear 
accelerator (LINAC) with MLC was used for beam delivery. A solid brass step jig was 
designed and built to conduct IMRT test with compensator. Two step and shoot 
sequences were programmed to conduct IMRT test delivery with MLC. The profiles of 
the two delivery techniques were measured and adjusted to match at isocenter depth of 10 
cm. Buildup dose at 1-5 mm depth was measured with an ultra-thin fixed volume parallel 
plate ionization chamber. Monte Carlo was used to model the brass step jig and step and 
shoot MLC sequences. The measured and simulated profiles for the two IMRT 
techniques were matched at isocenter depth of 10 cm. Component doses including MLC 
component dose was calculated. Mean spectral energy for open beam and compensated 
beam was calculated. 
 
(Intend to submit) 
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5.1  Synopsis 
 
Dose in the buildup region of a 6MV Varian LINAC was compared for IMRT delivery 
with solid modulators and MLC.  Near skin buildup dose of compensator treatment was a 
concern since compensator was closer to skin for Varian LINAC compared to existing 
machine. Dose was measured for 90 cm source to surface distance (SSD) and 106 cm 
SSD. The buildup depth was 1, 3, and 5 mm. Component doses including MLC 
component dose was calculated. Mean spectral energy was calculated for compensator. 
Buildup dose variation with SSD, field size and beam incidence angle was calculated. 
The agreement between the measured and calculated IMRT profiles for compensator and 
MLC was ±1.5 %.  
 
Key Words: Buildup dose, IMRT, step Jig, Monte Carlo, compensator, MLC 
 
5.2  Introduction 
 
Dose in the buildup region has been an area of interest in clinical radiation therapy even 
before 3D conformal therapy was introduced(58).  The modeling of the dose in the buildup 
region when using intensity-modulated radiation therapy (IMRT) treatments has been the 
subject of radiation physics research since the use of IMRT for head and neck cancer(59). 
Excessive dose in the buildup region can be the cause of significant patient discomfort 
and may lead to treatment interruptions, while underdosing in the buildup region may 
result in a local failure.  Most commercial planning does not model dose in the buildup 
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region well for small fields, such as the ones used in IMRT, and may not model the dose 
well with brass filters in the beam path. 
 
Many factors contribute to buildup dose, including the photon beam energy spectrum, 
scattered or contaminant electrons and their angular distribution, and scattered low 
energy photons.  Traditionally, these quantities are not modeled well in commercial 
treatment planning systems. As a result of this deficiency, current commercial treatment 
planning systems have difficulties in calculating dose in buildup regions, as reported by 
Chung, et al.(60). These authors found that two TPS overestimated surface dose by 7.4% 
to 18.5%. The dosimetrical differences in buildup regions between different treatment 
modalities, such as MLC-based versus compensator-based IMRT, cannot be accurately 
obtained by comparing treatment plans.  
 
IMRT(61) planning uses inverse planning algorithms(62) that generate idealized fluence 
maps for each field. The fluence maps then must be converted to either a series of MLC 
segments that are deliverable. There are two techniques for using the MLC to deliver the 
fluence maps: step and shoot, and sliding window.  In the step and shoot approach, each 
segment is formed, then the beam is turned on for the appropriate number of monitor 
units (units of delivered radiation).  Then the beam is held off and the next segment is 
formed, and the process repeats.  In the sliding window approach, slits of variable width 
move across the field and the dose rate is modulated.  
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The fluence map for each field can also be made deliverable using custom compensators. 
The desired fluence is sent to a computer controlled milling machine, which is used to 
mill out a solid brass plug to form a custom compensator for each field. The intensity is 
modulated by continuously varying the brass thickness. For each field, the associated 
compensator is placed in the beam path, typically in the wedge slot. Unlike the step and 
shoot delivery technique where only parts of the field are exposed to radiation at a time, 
the entire field is exposed in a static fashion. 
 
Another major difference between the two IMRT techniques is that the compensator is 
always mounted closer to the patient than MLC is. This geometric difference could 
change the dose in the buildup region. This geometry difference is largely due to 
accelerator design. Of the different LINAC designs, the Varian LINACs mount puts the 
compensators closest to the patient and early studies in MLC scatter and block scatter 
have shown that the closer the aperature, or in this case the compensator, the more scatter 
reaches the buildup region.  However, compensators also filter out low energy photons 
and eliminate low energy electrons that are scattered from the LINACs collimation 
system.  
 
Measuring dose in the buildup region is by itself an area of research. There is an absence 
of electron equilibrium and the finite size of the fixed volume ionization chamber creates 
an uncertainty as to the exact dose and the exact point of measurement.  Although the 
extrapolation chamber, which allows one to vary the chamber volume, is the detector of 
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choice for buildup dose measurements, this device is bulky, time consuming to use, and 
is not available in many clinical settings, perhaps due to its limited use. 
 
Fixed volume parallel plate ionization chambers are widely used to measure superficial 
dose. Velkley et al(63) proposed corrections to reduce the over-response of these 
chambers. The known over-response of these chambers at the surface has been compared 
with the extrapolation chamber and LIF thermo luminescent detectors and the authors 
proposed guidelines in use of such detectors(64). Chamber specific correction factors have 
been reported by others (Rawlinson et al)(65). Rawlinson modified Velkley’s correction 
factor for fixed volume parallel plate ionization chambers to include chamber geometry 
and wall material density. This correction factor was used in this study.  
 
Buildup dose was investigated for MLC-based IMRT and compensator-based IMRT 
delivery with a Varian (Varian Medical System Inc. Palo Alto, CA) linear accelerator 
(LINAC). To understand the differences in buildup doses between the delivery 
techniques, we commissioned a Monte Carlo code to calculate the buildup dose and 
component dose by components.  So the MLC scatter dose photons, electrons and the 
scatter from the compensator were all individually evaluated.  In addition, the mean 
spectral energy for compensators was calculated. Finally, the total doses and component 
doses were compared for the two delivery techniques.   
 
82 
 
5.3  Material and Methods 
 
5.3.1  Study Setup  
 
A brass step modulator was designed and built to deliver a simple IMRT profile for a 
single field using a 6MV beam on a Varian 2100.  The simple design would allow for 
relatively straightforward modeling of the resulting dose with Monte Carlo.  To create a 
similar profile at 10 cm depth, using an MLC to modulate the beam, a series of equivalent 
MLC steps were also created for step and shoot delivery with Varian Millennium MLC. 
A commercial linear diode array (Sun Nuclear Profiler, Sun Nuclear Corporation, 
Melbourne, FL) was set up to measure profiles of compensator and MLC steps at 
isocenter depth of 10 cm. By adjusting the index of the MLC segments and adjusting the 
MLC shapes slightly, the MLC profiles were then matched to the profile of the brass 
compensator. Doses at a variety of depths in the buildup region were measured in solid 
water using an ultra-thin fixed volume parallel plate ionization chamber connected to an 
electrometer.  
 
The MLC sequences and the brass modulator were modeled with Monte Carlo. The 
simulated parameters for the MLC and brass steps were adjusted to match their profiles to 
corresponding measured profiles at 10 cm depth.  
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5.3.2  Solid Brass Modulator 
 
The modulator is a 21x15 cm2 solid brass step as shown in Figure 23. It is mounted on an 
open port Plexiglas tray and inserted into the head of the machine so that the proximal 
surface of the compensator is 57.6 cm from the source or 42.4 cm from the phantom 
surface.  The distance from the distal surface of the compensator to the phantom surface 
varies from 41.8 to 35.4 (for 7 cm brass). 
 
 
 
Figure 23.  Brass modulator mounted on an open port Plexiglas tray inserted into upper 
wedge slot of LINAC. From left to right side of the figure, the step thickness is 7.62, 
5.08, 4.0, 0.6, 1.0, 2.0 and 3 cm. Step width varied from 2.5 to 3.4 cm projected at the 
isocenter. The effective Jaw setting was 21.4x15.4 cm2 at this plane.  
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5.3.3  MLC Step and Shoot Sequences 
 
Test fields were designed using the Varian MLC SHAPER program version 6.2. Because 
of the field width, a spilt field IMRT profile with seven step and shoot segments was 
designed to mimic the dose profile from the compensator at 10 cm depth.  
 
The initial design of each segment used was 3x15 cm2. The initial dose fraction values for 
each segment in a sequence, was estimated using equations 4 and 5.  BS1i is the beam-on-
time for segment i in sequence of the first field, and BS2i is the beam-on-time for segment 
i in sequence in the second field. For each MLC segment in sequence, the corresponding 
brass step thickness is x1i and x2i, µ (the effective linear attenuation coefficient) is 0.375 
cm-1,  
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Weighted segment profiles were added to obtain the MLC step profile. 
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The segment weight SW1i and SW2i is calculated using equations 6 and 7: 
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MUBSSW ii +∗=  (6) 
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222
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MUBSiSW i +∗=  (7) 
 
MU1 and MU2 are the monitor units set on the LINAC for sequence 1 and 2.  
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5.3.4  Matching Profiles at 10 cm Depth 
 
Profiles of compensator steps and MLC segments were measured using a commercial 
linear diode array.  The Profiler was set up so that the detector array was in a horizontal 
plane at 100 cm SSD (at isocenter), then 10 cm of solid water was placed on top of the 
Profiler. The profile generated from the compenator was carefully measured.  The profile 
generated from the MLC delivery initially did not match. The leaf positions for the MLC 
delivery were adjusted until the gradients in the profile of the MLC delivery matched that 
of the compensator.  Then the dose index for the MLC segments was adjusted to match 
the MLC profile to the compensator profile. 
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Finally the total number of monitor units was adjusted for the MLC delivery to deliver 
the same dose as the compensator plan.  For this adjustment, an ion chamber replaced the 
Profiler in the phantom. In the end, 729 MUs (600+129) were delivered for the MLC 
sequences and 262 MUs for the compensator. 
 
5.3.5  Chamber Measurements in the Buildup Region 
 
An ultra-thin window (0.02724 mm) fixed volume parallel plate ionization chamber 
(EXRADIN model A10, with the same collector diameter and electrode gap as Markus 
chamber) was connected to a MAX 4000 electrometer (Standard Imaging, Demingway 
WI). The chamber was set up in plastic water at 90 cm SSD. Chamber readings (nC) were 
obtained in the buildup region for individual slabs as well as for all steps of the two 
IMRT delivery techniques. The entire step and shoot sequence was run to obtain chamber 
response for each step. The chamber readings were corrected using Velkley’s correction 
factor which was modified by Rawlinson to account for geometry and wall material 
density, as in equation 10,  
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P/(d) is the corrected dose at depth d, P(d) is measured dose at d, the energy dependent 
factor C(E) is 27% for 6MV beam, l is plate separation, W is inner wall diameter, ρ  is 
wall material density, d is the depth to front surface of chamber, and dmax is the depth of 
maximum dose respectively. 
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5.3.6  Monte Carlo Modeling 
 
An EGSnrc(7)-based Monte Carlo simulation package for clinical radiation treatment 
units, BEAMnrc(34), was used to simulate the radiation from the Varian linear accelerator 
using either an MLC or brass compensators. The Varian Trilogy linear accelerator was 
first modeled for just open fields and tested against measured depth doses and dose 
profiles in a water phantom. Once this was completed a phase space file, in which are 
stored physical parameters (such as charge, energy, position, and direction) for all 
particles (photons and electrons) traversing the plane of interest, was scored below the 
secondary jaws. A total of 5x108 electrons with kinetic energy of approximately 6MeV 
incident on the target, were simulated to generate a phase space file. The phase space 
files were then used as radiation sources for MLC and compensator step simulations. 
 
The phase space files from MLC and compensator step simulations were used as 
radiation sources in phantom dose distribution calculations using DOSXYZnrc(13) 
(DOSXYZ user’s manual nrc report). In the DOSXYZ program the phantom geometry, 
compensator design, and, individual MLC profiles were defined. Water phantom 
simulations were done at 90 cm and 106 cm SSD.  The buildup dose was calculated in 
components: the primary photon dose, the scattered radiation dose and electron 
contaminant dose. The energy fluence distribution for open beams and with a 2 cm thick 
slab of brass in the beam were calculated to show the effect of beam hardening with 
compensators. 
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The physical width and dimension of the brass steps were carefully measured and 
modeled using the component module BLOCK in which the compensator divergence was 
accounted for. For the MLC, each segment dimension was adjusted and simulated 
accordingly. The accelerator models are shown in Figure 24 (a, b). The weight for each 
MLC segment were defined by the monitor units delivered in each segment divided by 
the total number of MUs used to deliver the MLC pattern.   
 
 
 
Figure 24.  Monte Carlo model of Varian accelerator head geometry. Major parts such as 
the target, primary collimator, flattening filter, transmission chamber and jaws are shown 
in panel a. MLC, the step wedge and the phantom top is shown in panel b.  The measured 
and calculated doses were normalized to the calculated 10 cm depth point along the 
central axis.  Buildup dose at shallow depths were then calculated with Monte Carlo. 
 
 
The depth dose in the buildup region along the IMRT beam axis was calculated. The 
percent of dose difference of the two IMRT techniques in the buildup region as a function 
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of step modulation was measured. Depth dose for individual slabs of solid brass was 
calculated as a function of brass thickness, field size, and source to surface distance. 
Energy spectral variation for open and compensated field was calculated. The 
contaminant dose component in the buildup region was calculated. Buildup dose 
contributed from photons and electrons that were interacted in MLC were calculated.  
 
5.3.7  Dose in Buildup Versus Source Surface Distance 
 
Dose at 1.0 mm depth with extended SSD was also calculated. This is done to 
approximate the dose difference with a different SSD which may occur with varying 
patient treatment techniques and also with different accelerator geometries if a linear 
accelerator other than a Varian is used. This only approximates the differences one would 
see with a different accelerator, as a complete simulation of the other accelerator would 
be required. To approximate the effect due to the modulator to surface distance change, 
but not SSD change, all the results from both measurements and calculations were 
corrected using Mayneord’s F factor. 
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5.4  Results 
 
5.4.1  Dose Profile Match at 10 cm Depth 
 
Matched profiles of solid modulator and step and shoot MLC at isocenter depth of 10 cm 
is shown in Figure 25. Agreement between the measured and calculated profiles was 
better than ±1.5%.  
 
 
Figure 25.  The matched profiles of IMRT delivery with step and shoot and solid 
modulator.  Center of 6MV beam traverses the thinnest part of the modulator which is 0.6 
cm thick brass. 
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5.4.2  Dose Comparison at Shallow Depths 
 
Agreement between the Monte Carlo and measured data of 3 % or better was achieved 
for the more clinically relevant IMRT steps of (1, 2 and 3 cm thick) at 1, 3 and 5 mm 
depth in reference to 10 cm depth, as in Tables 6, 7 and 8. 
 
The measured and calculated dose in cGy (given 100 cGy delivered at isocenter) for the 
most commonly used clinical compensator with equivalent step thickness of 2 cm, were 
47 and 44.0±1.0 for compensator compared to 52 and 49.0±1.5 for MLC at 1 mm depth 
in Table 6. Table 7 shows the same values for 3 mm depth were 71 and 70.0±1.8 for 
compensator compared to 75 and 76.0±2.3 for MLC. The same values at 5 mm depth 
were 83 and 82.0±1.6 for compensator and 90 and 89.0±2.3 for MLC in Table 8. Tables 
show the same trend of lower compensator dose compared to MLC for more clinically 
relevant 1 cm and 3 cm thick equivalent steps. 
 
Table 6.  Doses (cGy) of IMRT delivery with solid modulator and MLC as a function of 
STEP thickness of the compensator at 1 mm depth.  Doses were calculated with Monte 
Carlo and measured with parallel plate ionization chamber at 90 SSD, 0.1 cm depth and 
normalized to dose at isocenter, assuming 100 cGy was delivered at the isocenter. 
 
STEP 
cm 
COMP MLC 
Calculated Measured Calculated Measured 
0.6 69.0±1.0 69 71.0±1.4 70 
1.0 62.0±1.0 64 66.0±2.0 68 
2.0 44.0±1.0 47 49.0±1.5 52 
3.0 30.0±1.0 30 36.0±1.1 34 
4.0 27.0±1.0 29 29.0±1.0 31 
5.08 20.0±1.0 21 22.0±1.1 24 
7.62 13.0±1.0 12 13.0±1.0 13 
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Table 7.  Doses (cGy) of IMRT delivery with solid modulator and MLC as a function of 
STEP thickness of the compensator at 3 mm depth.  Doses were calculated with Monte 
Carlo and measured with parallel plate ionization chamber at 90 SSD, 0.3 cm depth and 
normalized to dose at isocenter, assuming 100 cGy was delivered at the isocenter. 
 
 
STEP 
cm 
COMP MLC 
Calculated Measured Calculated Measured 
0.6 113.0±1.7 109 116.0±2.3 113 
1.0 100.0±2.0 98 104.0±2.1 102 
2.0 70.0±1.8 71 76.0±2.3 75 
3.0 50.0±1.5 48 55.0±1.7 53 
4.0 39.0±1.2 39 41.0±1.2 43 
5.08 27.0±1.1 27 31.0±1.2 31 
7.62 15.0±1.0 15 16.0±1.0 15 
  
Table 8.  Doses (cGy) of IMRT delivery with solid modulator and MLC as a function of 
STEP thickness of the compensator at 5 mm depth.  Doses were calculated with Monte 
Carlo and measured with parallel plate ionization chamber at 90 SSD, 0.5 cm depth and 
normalized to dose at isocenter, assuming 100 cGy was delivered at the isocenter. 
 
STEP 
cm 
COMP MLC 
Calculated Measured Calculated Measured 
0.6 136.0±2.0 133 138.0±2.8 135 
1.0 118.0±1.8 119 123.0±2.8 122 
2.0 82.0±1.6 83 89.0±2.3 90 
3.0 58.0±1.5 57 62.0±1.9 60 
4.0 45.0±1.1 46 47.0±1.6 49 
5.08 32.0±1.1 32 34.0±1.4 35 
7.62 17.0±1.0 16 17.0±1.0 16 
 
 
Figure 26 shows percent of dose difference as a function of step modulation for IMRT 
with MLC versus compensator. The difference increased with compensator thickness 
reaching the maximum value of 17% for the equivalent of 5 cm thick brass step at 1 mm 
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depth dropping to 8% at 5 mm depth. It decreased with further increase in modulation or 
brass thickness, and depth. 
 
 
 
Figure 26.  Percent of dose difference for IMRT test delivery with MLC with respect to 
compensator is shown as a function of step modulation (thickness) for 1, 3 and 5 mm 
depth.  Note the maximum difference occurs for the 5 cm thick step for all depths and is 
highest for 1 mm depth. The value is about 17%. 
 
 
5.4.3  Shallow Dose Variation with SSD 
 
Figure 27 shows dose variation with SSD. Dose at 1 mm depth for open beam and beam 
attenuated with 1 cm brass was 71 and 64 and did not change with SSD; however. dose 
for 5.08 cm brass decreased 10.5% from 56.0 to 45.5 for 90 to 106 cm SSD. 
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5.4.4  Shallow Dose Variation with Field Size 
 
Figure 28 shows dose variation with field size. Dose increased 10 percentage points  
(67% to 77%) for open beam of (5x5-20x20) cm2.  Dose increase was 12 percentage 
points (58% to 70%) for 1 cm brass and 25 percentage points (43% to 68%) for 5.08 cm 
brass.  
 
 
 
Figure 27.  Buildup dose variation with SSD for open and compensated fields. Note the 
bottom two curves show the largest variation in buildup dose with SSD for the 5.08 cm 
thick compensator. 
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Figure 28.  Dose variation with field size. Dose variation for 2, 5, 10, 15 and 20 cm2 
fields is presented for open and compensated fields at 1 mm depth. 
 
 
5.4.5  Energy Spectra Variation for Open and Compensated Field 
 
The average spectral energy of photons was 1.57 MeV for open beam and 2.17 MeV for 
2 cm thick brass, as shown in Figure 29. 
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Figure 29.  Normalized planar energy fluence distribution of 6MV beam for 2x15 cm2 
field.  
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5.4.6  Dose Contributions of Various Components 
 
Calculated Component doses of solid modulator and step and shoot MLC as percentage 
of total dose is shown in Table 9. 
 
Table 9.  Monte Carlo percent of total dose contribution from scattered photons, 
contaminant electrons and MLC.  Dose at 1.0 mm depth was scored in a 1.5 cm2 square 
region centered on the central axis. Set up SSD was (a)=90 cm and (b)=106 cm. 
 
IMRT Total dose 
 
cGy 
Scattered 
Photons 
% 
Contaminant 
Electrons 
% 
MLC 
Component 
% 
Solid 
modulator 
(a) 
 
69.0±1.0 
 
 
81 
 
19 
 
0.08 
Step and 
shoot 
(a) 
 
71.0±3.1 
 
82 
 
15 
 
3.0 
 
Solid 
modulator 
(b) 
 
50.0±1.0 
 
82 
 
18 
 
0.08 
Step and 
shoot 
(b) 
 
54.0±2.7 
 
 
80 
 
18.0 
 
2.0 
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5.4.7  Scatter Photon Dose Contribution 
 
The primary photons are those generated in the target and pass directly through the 
flattening filter reaching the phantom surface on the axis with a narrow angular spread 
and bear minimal scatter component. The contaminant photons or electrons have 
interacted in and scattered from accelerator head components such as the jaws or MLC 
before reaching the phantom surface. 
 
These components were differentiated in phantom dose calculation in BEAMnrc. For 
example, the latch bit filtering in BEAMnrc was used to tag the scattered dose from the 
MLC. This was accomplished by setting bit 5, for example, in the MLC component 
module to be associated with this region for use with the bit filters applied when dose 
components are used. Total dose and dose components were selected for dose calculation 
in BEAMnrc input file. The particles that were interacted and scattered from MLC 
entering the phantom were defined to be contaminant. The contaminant type was set to 
either photon or electron. Finally, the number of dose components inclusive bit filters 
was defined to include the associated component latch bit filters for component dose 
calculation. 
 
Low energy scatter photon dose contribution at 1.0 mm depth was 82% of total dose for 
compensator and 84% of total dose for step and shoot delivery at 90 cm SSD. At 106 cm 
SSD, these values did not change significantly and were 84% of total dose for 
compensator and 80% of total dose for step and shoot delivery techniques respectively. 
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5.4.8  Contaminant Electron Dose Contribution 
 
Contaminant electron dose contribution was significantly lower compared to that from 
scattered photons at 1 mm depth. Dose contribution at 90 cm SSD was 18% of total dose 
from solid modulator compared to 12% of total dose from step and shoot delivery. The 
corresponding values at 106 cm SSD were 16% and 18% of total dose respectively. 
 
Our preliminary calculations in the buildup region at shallower depths near the skin 
showed low energy contaminant electrons and photons contributed nearly equally to total 
dose. However, the focus of this study was to assess buildup dose between 1-5 mm depth. 
 
5.4.9  MLC Component Dose Contribution  
 
MLC scatter contribution to total dose was less than 0.1% for solid modulator and 2% for 
step and shoot delivery. MLC component dose contribution was about 4% of total dose at 
shallow depths at 90 cm SSD and 2% at 106 cm SSD respectively. 
 
5.5  Discussion 
 
The results presented here were limited to simple IMRT tests conducted for the step jig 
device, however the conclusions that were drawn can be extended to the actual IMRT 
plans. The magnitude of this effect is similar to the effect we would expect to see with 
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large field IMRT plans where the smallest segments are no wider than 2 cm. In cases 
with much higher degrees of modulation, the MLC scatter would increase. 
Usually in treatment planning system calculations, the voxel size is 2-3 mm, and TPS 
dose calculation uncertainty greatly increases at shallower depths. The dosimetric 
uncertainty in this region is also pronounced even with Monte Carlo calculations. As the 
simulation thickness becomes smaller to accommodate calculations at shallower depths, 
the number of particles interacting in such a thin slab is extremely sparse, hence to 
perform a calculation with small uncertainty a prohibitively large number of histories 
would be required to achieve the requisite statistics.  
Also, in a separate but related study, Opp et al. analyzed previously planned cases using 
IMRT with solid compensatrors.  In this work, a histogram of transmission factors 
(plotted by compensator thickness) for 10 cases (with a total of 50 brass modulators) was 
generated, it is clear that the most probable compensator thickness as weighted by 
transmission factor (or dose) was just under 2 cm. as shown  in Figure 30. 
 
101 
 
 
Figure 30.  Most probable compensator thickness from 50 retrospective IMRT field 
analysis (Opp et al.). 
 
The step wedge IMRT simulation calculations for Varian LINAC show dose in the 
buildup region at depth of 5 mm is 7% lower for compensators with equivalent thickness 
of 2 cm modulation, compared with MLC. This dose reduction is due to beam hardening 
of compensators. We conclude that dose at 5 mm depth in the buildup region is 7% lower 
for compensator- based IMRT compared with MLC-based IMRT delivery on the 6MV 
Varian Trilogy linear accelerator.  
Simulation data indicate dose contribution from MLC at 1 mm depth was less than 3% of 
total skin dose for step and shoot test delivery. This is partly due to transmission of useful 
beam through closed MLC leaves (~ 2% for Varian MLC) and partly due to contaminant 
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radiation emitted from interaction of primary beam with the edges of open MLC 
segments.  
 
5.5.1  Measured Dose Gradient 
 
Note that making measurements in the buildup region are difficult due to steep dose 
gradients. The measured dose varied 17%/mm between depth of 2 and 3 mm and 
10%/mm between 4 and 5 mm depth. 
 
Acute skin toxicity with step and shoot IMRT for head and neck has been attributed to 
many factors, including multiple tangential beams, the beam obliquity and the bolus 
effect of immobilization mask for the head and neck treatments(66).  Authors indicated the 
average skin dose was 18% larger than the treatment planning system indicated, due to a 
variety of effects, including the bolusing effect of the mask and beam obliquity.  
 
5.6  Conclusion 
 
Low energy scattered electrons emerging from accelerator head for the step and shoot 
and brass modulator delivery were major contributors to dose in the buildup region near 
the surface, which sharply decreased in magnitude while that of photons increased with 
depth beyond 1 mm, however contaminant contribution from the photons scattered off 
the MLC increased over the first few millimeters in the buildup region.  
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The closer the modulator is to the patient, the higher skin dose the patient would get, due 
to the larger solid angle to the scattered low energy photons and electrons from the 
accelerator head. In all accelerator configurations, the brass compensator is always closer 
to the patient than the MLC is. However, Monte Carlo simulations in this study indicate 
that compensator dose was 5%, 6% and 7% lower than MLC dose at 1 mm, 3 mm and 5 
mm depth for modulation equivalent to 2 cm of brass. Beam hardening in the 
compensator modality is the major reason for its shallow-depth dose sparing in the 
buildup region. Further extended SSD measurements and simulations in this study 
suggest that the use of accelerators other than Varian’s, which usually have smaller 
heads, thus larger modulator to surface distance, would further reduce the dose in the 
buildup region when using compensators.  
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CHAPTER 6  CONCLUDING REMARKS 
 
The dose in the first few millimieters of the build up region is most strongly influenced 
by beam spectrum and the SSD.  The more the engery spectrum is shifted to higher 
energy the lower the dose in the buildup region. Similarly the greater the SSD the more 
the dose in the buildup region is reduced. 
 
In the case of compensators the spectrum is shifted to higher engeries due to beam 
hardening, and the compensator also filters out the low energy scattered photons and 
electrons resulting in lower dose in first few millimeters of the the buildup region.    
 
In the case of the Tomotherapy unit the beam has no flattening filter resulting in an 
energy spectrum that is shifted to lower energies, and the treatments use a smaller SSD.  
Also the beam angles played a role as beams from shallow angles have longer path 
lengths.  
 
6.1  Recommendations for Future Work 
 
In radiation oncology there are times when getting a higher dose in the buildup region is 
desirable, such as in the post-operative setting where cancer cells may have seeded along 
the surgical scars.  In other cases this high dose in the buildup region can cause unwanted 
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skin reaction and breaks in a patient’s treatment.  However there is precious little 
knowledge of exactly what dose to what depth will cause the desired or undesired effects.  
A clinical investigation may be able to address this issue. 
 
The measurements in the first 4 mm of the buildup region in our work have significant 
uncertainty.  Repeating these measurements with an extrapolation chanber may result in 
much more accurate measurements which we believe would be in better agreement with 
our Monte Carlo results.   
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